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Abstract 
Genomic imprinting is an epigenetic phenomenon that restricts gene expression to one parental 
allele while the other copy is silent. How this duality is regulated is not fully understood. Using 
the Kcnq1ot1 imprinted domain as a model, previous work in the laboratory identified 
nucleoporin 107 as a candidate regulator of imprinted domain regulation. Within the Kcnq1ot1 
domain resides the imprinting control region, the paternally expressed Kcnq1ot1 (Kcnq1 
opposite transcript 1) noncoding RNA, nine maternal-expressed protein-coding genes, as well 
as genes that escape imprint regulation. On the maternal allele, the Kcnq1ot1 imprinting control 
region is methylated, silencing the embedded Kcnq1ot1 promoter and its transcription, and 
thereby permitting expression of neighbouring genes. On the paternal allele, the Kcnq1ot1 
imprinting control region is unmethylated, allowing Kcnq1ot1 noncoding RNA transcription, 
which results in neighbouring protein-coding gene silencing. In the present study, I showed 
that depletion of nucleoporin 107, nucleoporin 62 and nucleoporin 153 in mouse 
extraembryonic endoderm stem cells reduced Kcnq1ot1 noncoding RNA expression and 
volume, decreased Kcnq1ot1 imprinted domain positioning at the nuclear rim and reactivated 
normally silent paternal alleles of a core group of protein-coding genes in the domain. Paternal 
alleles of additional protein-coding genes were also reactivated but in a nucleoporin-specific 
manner. While DNA methylation at the Kcnq1ot1 imprinting control region was not changed, 
nucleoporin 107, nucleoporin 62 and nucleoporin 153 depletion led to alterations in active and 
repressive histone modifications and a reduction in cohesin complex protein interactions at the 
Kcnq1ot1 imprinting control region. Therefore, I identified a novel mechanism of imprinted 
domain regulation, namely nucleoporin-mediated imprinted domain regulation at the Kcnq1ot1 
domain in extraembryonic endoderm stem cells. Next, I demonstrated that this novel 
nucleoporin-mediated mechanism also regulated the Kcnq1ot1 imprinted domain in embryonic 
stem and trophoblast stem cells, albeit for a different subset of genes. While CTCF and the 
cohesin complex interacted at the same sites within the paternal Kcnq1ot1 imprinting control 
region in a NUP107, NUP62 and NUP153 dependent manner in embryonic stem cells, 
trophoblast stem cells lacked CTCF and cohesin binding at the Kcnq1ot1 imprinting control 
region. My results establish an important role for nucleoporins NUP107, NUP62 and NUP153 
in mediating imprinted domain regulation in all three cell lineages. 
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Chapter 1  
1 Introduction 
1.1 Epigenetics 
Gene expression and its regulation are essential for embryonic development and 
differentiation.  Gene expression is orchestrated by sets of proteins that bind to gene 
regulatory elements. These elements include promoters, insulators, enhancers and silencers 
(Wallace and Felsenfeld, 2007). In eukaryotes, interaction between enhancer elements and 
gene promoters results in gene activation. These interactions can occur at a distance of a 
few hundred base pairs to 100 kb or more (Sanyal et al., 2012). The process of regulating 
gene expression through transcription factor binding and RNA polymerase II mediated 
transcription is well studied (Egecioglu and Brickner, 2011; Hakim et al., 2010; Meldi and 
Brickner, 2011). However, other mechanisms govern gene expression beyond DNA 
sequence information. These mechanisms are termed as epigenetic mechanisms. 
Epigenetics was originally described by Waddington in 1942 as the branch of biology that 
studies interactions between genes and their products, which bring the phenotype into being 
(Waddington, 2012). Today, epigenetics is defined as heritable changes of gene expression 
that are not caused by changes in primary nucleotide sequence of the DNA (Gibney and 
Nolan, 2010). To store the genetic information within eukaryotic cells, DNA is wrapped 
around histones to form nucleosomes that are the basic unit of chromatin. This structure 
allows efficient reading of the DNA as well as accessibility to the DNA template. Each 
nucleosome contains an octamer of histones that is comprised of two copies each of H2A, 
H2B, H3 and H4 (Bártová et al., 2008). The two central mechanisms that directly regulate 
how chromatin is packaged are DNA methylation and histone modifications (Jenuwein and 
Allis, 2001; Li et al., 1993). Chromatin packaging can also be regulated by chromatin 
remodeling proteins as well as noncoding RNAs. All together, these mechanisms are 
involved in regulating gene expression. Recent advances in high resolution microscopy 
have shown that the three-dimensional conformation of chromatin within the nucleus as 
well as nuclear architecture play key roles in gene expression and regulation (Cremer and 
Cremer, 2010; Smeets et al., 2014). Proteins such as CTCF and the cohesin complex are 
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involved in 3D chromatin conformation, acting to establishing boundaries that separate 
heterochromatin and euchromatin (Hark et al., 2000; Yusufzai et al., 2004). For nuclear 
architecture, sub-nuclear compartments such as the perinucleolar region and the nuclear 
membrane, comprised of nuclear lamina and nuclear pore complexes play significant roles 
in activating or silencing gene expression (Pombo and Dillon, 2015; Ptak and Wozniak, 
2016). Below, I discuss the various epigenetic mechanisms in detail that regulate gene 
expression. 
 
1.2 Epigenetic Mechanisms 
1.2.1 DNA Methylation 
DNA methylation is the addition of a methyl group to the 5'-position of a cytosine residue 
and is often correlated with transcriptional repression (Figure 1-1). In mammals, cytosine 
methylation most commonly occurs when its neighbor is a guanine, which is denoted as a 
CpG dinucleotide. DNA methylation is carried out by a group of proteins called DNA 
methyltransferases (DNMTs). DNMT3A, 3B and 3L are responsible for de novo DNA 
methylation (Li, 2002; Li et al., 1993). Once DNA methylation is acquired, it is maintained 
by DNMT1. During DNA replication, DNMT1 recognizes hemi-methylated DNA, adding 
methyl groups to the newly synthesized DNA strand (Okano et al., 1999). DNA 
methylation is a highly stable mark (Chodavarapu et al., 2010). As such, it is important for 
genomic stability, chromatin structure, genomic imprinting, and silencing of repetitive 
elements (reviewed in Rodenhiser and Mann, 2006). Aberrant DNA methylation can result 
in changes in gene expression, cancer and genomic imprinting disorders. 
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Figure 1—1: DNA methylation 
DNA methylation is the covalent addition of a methyl group (CH3, red) to the 5' position 
of the pyrimidine ring of cytosine residues. Methyl groups are most commonly added to 
cytosine residues within CpG dinucleotides. This addition is catalyzed by DNA 
methyltransferases. DNA methylation at CpGs generally results in a more compact state of 
chromatin, inhibiting transcription. When CpGs are unmethylated, chromatin is in a more 
relaxed state, and can be transcribed. Open circles (white) represent unmethylated CpGs, 
while closed (red) circles represent methylated CpGs. 
  
Un-methylated DNA
Methylated DNA
Unmethylated CpG Methylated CpG
CH3
DNA methyltransferases
Active transcription
Cytosine
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1.2.2 Histone Modifications 
Histones are the protein components of chromatin. They are subjected to a wide variety of 
post-translational modifications, including acetylation, methylation, phosphorylation, and 
sumoylation. These modifications are heritable during cell division and play a significant 
role in gene expression (Bannister and Kouzarides, 2011; Brown et al., 2008; Desvoyes et 
al., 2010; Martens et al., 2005). Histone modifying enzymes specify different histone 
modifications that are involved in regulating gene expression. Histone methyltransferases 
(HMTs) catalyze the transfer of methyl groups to lysine and arginine residues of histones. 
Different HMTs modify specific methyl states, mono, di or tri, for example, H3K4me1, 
H3K4me2, and H3K4me3. Histone demethylases (HDMs) are proteins that have the 
catalytic ability to remove methyl groups from lysine and arginine residues of histones 
(Mozzetta et al., 2015; Zentner and Henikoff, 2013). An active or repressed state for 
chromatin depends on the histone modification conferred to the histone tails. For example, 
tri-methylation of lysine 4 of H3 (H3K4me3) has been associated with active chromatin, 
whereas di- and tri-methylation of lysine 9 (H3K9me2/3) and tri-methylation of lysine 27 
of H3 (H3K27me3) have been correlated with inactive chromatin (Figure 1-2) (Tessarz and 
Kouzarides, 2014).  
 
Active or repressed chromatin is also specified by the acetylation state of chromatin. 
Euchromatin is characterized by histone acetylation, which is catalyzed by histone acetyl 
transferases (HATs). Histone acetylation neutralizes the positive charge on histones, 
resulting in a more open chromatin state. Conversely, histone deacetylases (HDACs) 
remove acetyl groups, re-establishing the positive charge to histone tails, thereby enabling 
their interaction with negatively charged DNA and the formation of heterochromatin. 
Histone phosphorylation, ubiquitination and sumoylation are other histone modifications 
that are not as intensively studied but play a role in gene regulation (Bannister and 
Kouzarides, 2011). For example, during interphase phosphorylation of serine 10 in histone 
H3 is correlated to an active chromatin state, whereas H2A phosphorylation is associated 
with a repressed state (Fischle et al., 2005; Hirota et al., 2005). Histone modifications can 
co-exist and a particular histone profile can provide binding sites for other chromatin-
binding proteins that promote active or repressed  state. 
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Figure 1—2: Histone Modifications 
Post-translational modifications of histone tails can modulate gene expression.  Active 
modifications (green) represented by H3K4me3 and H3K9ac promote an active chromatin 
state, thereby enabling gene expression. Repressive histone modifications (red) represented 
by H3K9me2/3 and H3K27me3 are associated with inactive genes and promote a compact 
chromatin state. Histone methyltransferases (HMTs) confer methyl groups on histone tails, 
while histone demethylases (HDMs) remove these methyl groups. Histone 
acetyltransferases (HATs) add acetyl groups, while histone deacetylase (HDACs) remove 
acetyl groups.  Through these histone modifications, chromatin remodeling proteins can 
bind, altering the structure of chromatin, thereby inducing transcriptional activation or 
repression. 
Unmethylated CpG
Methylated CpG
Active transcription
H3K4me3 H3K9ac
H3K27me3
H3K9me2/3
H3K4me3
H3K9ac
H3K9me2/3
H3K27me3
HMTs/HDMs
HDACs
HMTs/HDMs
HATs
6 
 
1.2.3 Noncoding RNAs 
In mammals, the majority of the genome (>85%) is composed of regions that are 
transcribed, although many of the resulting RNAs are not translated (Hangauer et al., 
2013). These transcripts are known as noncoding RNAs (ncRNAs). Noncoding RNAs are 
classified into two groups based on size (Cheetham et al., 2013). Small noncoding RNAs 
are less than 200 nucleotides in length while long non-coding RNAs are greater than 200 
nucleotides. Small ncRNAs, such as microRNAs, short interfering RNAs, PIWI-RNAs, 
and small nucleolar RNA, repress translation by binding to their target sequence, initiating 
the RNA interference pathway, where the RNA will be degraded. Long noncoding RNAs 
are transcribed both sense and antisense to coding sequences with their transcription start 
sites being either intronic or intergenic. Many long ncRNAs contain features similar to 
mRNAs, including a 5' 7-methyl guanosine cap and 3' polyA-tail (Meller et al., 2015). It is 
currently unclear how long ncRNAs mediate gene expression and overall chromatin 
structure. A common feature of most long ncRNAs is that transcripts are confined to the 
nucleus, suggesting the transcript itself may be functionally important in directing 
expression (Furuno et al. 2006; Derrien et al. 2012). Three mechanisms have been proposed 
for long ncRNAs cis function: transcriptional interference, coating of chromatin and 
recruitment of epigenetic repressors (Figure 1-3). Transcriptional interference occurs when 
transcription of the long ncRNA overlaps the promoter of the target gene, disrupting RNA 
polymerase recruitment. For chromatin coating, a long ncRNA spreads from the site of 
transcription to cover the neighbouring chromosomal region, inducing a repressed 
chromatin conformation. Finally, long ncRNAs, through a secondary conformation, may 
act as adaptors to recruit chromatin modifiers, such as histone methyltransferases, to 
chromosomal regions, inducing gene silencing. More studies are required to further 
understand how long noncoding RNAs regulate gene expression. 
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Figure 1—3: Mechanisms of long noncoding RNA-mediated gene silencing 
Long noncoding RNAs are proposed to regulate gene silencing by the following methods. 
A: Transcriptional interference. Transcription of a long ncRNA through the promoter of a 
gene abrogates transcription factor (TF) and RNA polymerase II (RNAPII) binding at the 
promoter, thereby silencing genes. B: Coating the domain in cis. Long ncRNAs spread in 
cis coating the domain, inducing a repressed chromatin conformation that silences 
neighbouring genes. C: Recruitment of silencing factors. Long ncRNAs may function as 
adaptors, recruiting histone modifying enzymes to chromatin, thereby silencing 
neighbouring genes.   
Long noncoding RNA
Gene
TF
Long noncoding RNA
Gene
Long noncoding RNA
Gene
A: Transcriptional interference model
B: Noncoding RNA coating domain model
C: Noncoding RNA recruiting chromatin remodellers
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1.3 Chromatin Organization 
The mammalian genome is highly organized within the 3-dimensional (3D) space of the 
nucleus. On a macro scale, chromosomes are highly organized within the nucleus, forming 
distinct territories that do not overlap with other chromosomes, which are termed as 
chromosome territories (Cremer and Cremer, 2001; Cremer and Cremer, 2010; Smeets et 
al., 2014). Furthermore, contiguous regions along the chromosome are organized by 
chromatin topologies, which encompass local chromatin-chromatin interactions and their 
associations within the nucleus. Proteins such as CCCTC-binding factor protein CTCF and 
its binding partner the cohesin complex have key roles in chromatin-chromatin 
interactions, that give rise to chromosome territories. Formation of chromosome territories 
at different sub-nuclear compartments results in formation of active and silenced domains. 
These chromatin structures are facilitated by nuclear architecture, which comprises the 
scaffold on which chromosome territories and chromatin topologies are formed. Included 
are features such as the nuclear lamina, nuclear pore complex, nuclear scaffold/matrix and 
the nucleolus. Associations of chromatin with nuclear architecture have a direct influence 
on chromatin topology, indicating that nuclear positioning is key to gene expression.  
1.3.1 Topologically Associated Domains 
Over the years, various terms have been used to describe the organization of chromatin into 
domains depending on the method used for demarcation. One emerging methodology that 
utilizes chromatin capture revealed that the genome is organized into topologically 
associating domains (TADs). TADs represent ~1 Mb chromatin domains, that are enriched 
for chromatin-chromatin interactions while interactions between neighbouring domains are 
low (Figure 1-4) (Dixon et al., 2012; Nora et al., 2012; Pope et al., 2014). Remarkably, 
TADs are largely stable across cell types and conserved between species (Dixon et al. 2012; 
Nora et al. 2012). This suggests that generally TADs are not indicative of a particular 
transcriptional state, and that higher-order chromatin associations remain stable even with 
a transcriptional state change. Thus, TADs have been proposed to represent the linear 
segregation of the genome into regulatory neighbourhoods. By comparison, variations in 
subtopologies within TADs, and changes in DNA replication timing of a TAD, occur in 
distinct cell types (Phillips-Cremins et al., 2013; Pope et al., 2014). Generally, these 
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substructures are achieved by specific looping of chromatin within TADs (Jin et al., 2013; 
Phillips-Cremins et al., 2013; Rao et al., 2014). 
 
1.3.2 CTCF and the Cohesin Complex  
Two factors mediate local chromatin-chromatin interactions in mammals, CTCF and the 
cohesin complex. CTCF is a multifunctional protein known for its role as an insulator 
protein. CTCF binds to its consensus sequence within chromatin, then forms homodimers 
that generate chromatin loops (Phillips and Corces, 2009). The cohesin complex consists 
of four subunits, which include RAD21/sister chromatid cohesin protein 1 (SSC1), SSC3, 
structural maintenance of chromosome 1 (SMC1) and SMC3. The cohesin complex forms 
a ring-like structure capturing and holding chromatin strands together, assisting in the 
chromatin loop formation (Nasmyth and Haering, 2009; Phillips and Corces, 2009). 
Cohesin binding frequently overlaps with that of CTCF to regulate chromatin topology 
(Figure 1-4) (Handoko et al., 2011; Schmidt et al., 2010). Recent high-resolution 3D 
mapping of chromatin places a conservative estimate of ~10,000 loops in the human 
genome, the majority of which are anchored by CTCF (Rao et al. 2014). Because of their 
role in loop formation, CTCF and cohesin demark regions between different chromatin 
loops, generating chromatin boundaries (Figure 1-4). While mostly enriched within TADs 
to form sub-TAD chromatin loops (Phillips-Cremins et al. 2013), CTCF binding sites are 
also enriched at TAD boundaries (Dixon et al. 2012). Interestingly, independent depletion 
of CTCF or cohesins subunits has distinct effects on chromatin interactions. CTCF 
depletion results in decreased interactions within TADs as well as increased interactions 
between TADs (Zuin et al., 2014). Depletion of RAD21 also reduced subtopological 
chromatin interactions within TADs, although the TADs themselves were not disrupted.  
These results support previous findings that chromatin interactions are not strictly 
dependent on the presence of CTCF or cohesin, but rather that 3D chromatin structure is 
supported by multiple factors (Phillips-Cremins et al. 2013).  
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Figure 1—4: Chromatin organization within the nucleus 
The mammalian genome is highly organized into chromatin topologies via interactions 
with the nuclear architecture. Topologically associated domains (TADs) segregate the 
genome into regulatory neighbourhoods, which are enriched for chromatin-chromatin 
interactions that facilitate subTAD chromatin looping. CTCF and cohesin play a role in 
generating these subTAD chromatin interactions, as well as marking TAD boundaries. 
Lamin associated domains (LADs) are regions of chromatin that are bound to Lamin B1, a 
major component of the nuclear lamina, linking chromatin with low to no transcription to 
the inner nuclear membrane. Nucleolar associated domains (NADs) describe chromatin 
with low transcriptional activity that localize to the perinucleolar region. NADs partially 
overlap with LADs, with a possible shift of chromatin between LADs and NADs during 
the cell cycle or in different tissues. Scaffold/matrix attachment regions (S/MARs) are 
DNA loci that have a high affinity for the nuclear scaffold/matrix and have been associated 
with repressed and active chromatin. Nucleoporin-associated chromatin (NUPAC) 
describes nucleoporin/nuclear pore complex interactions with active chromatin, facilitating 
chromatin looping and demarcating chromatin boundaries. 
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1.3.3 Scaffold/matrix Attachment Regions  
Chromosome territories are maintained in part through interactions with the nuclear 
scaffold/matrix. Scaffold/matrix attachment regions (S/MARs) are DNA loci that have a 
high affinity for the nuclear scaffold/matrix after the depletion of histones and other soluble 
factors (Mirkovitch et al. 1984; Cockerill and Garrard 1986). S/MARs are significant in 
that they provide a direct connection between chromatin and the nuclear scaffold/matrix 
that is independent from the histone state, indicating an important role in nuclear 
architecture (Figure 1-4). In human cell lines, disruption of the nuclear scaffold/matrix 
releases S/MAR associated proteins and leads to the disorganization of chromosomal 
territories (Ma et al. 1999). Almost 100 S/MAR-binding proteins have been identified in 
model organisms, including lamins, topoisomerases, AT-rich binding proteins and histone 
deacetylases (Liebich et al., 2002a; Mika and Rost, 2005). The DNA sequences of S/MARs 
are highly polymorphic, without any common motif enrichment, suggesting a dynamic role 
for S/MAR association with the nuclear scaffold/matrix (Liebich et al., 2002b). That being 
said, S/MARs are enriched for AT-rich elements but not for CTCF binding sites (Goetze 
et al., 2005). This suggests that S/MARs are unlikely to primarily serve as anchors for 
CTCF/cohesin-mediated chromatin loop formation but may serve specific roles for 
chromatin access and loop scaffolding.  
 
1.3.4 Nucleolar Associated Domains  
Besides the nuclear periphery, chromatin also associates with the nucleolus, in what are 
defined as nucleolar associated domains (NADs) (Figure 1-4) (Németh et al. 2010; van 
Koningsbruggen et al. 2010). The nucleolus is the largest subnuclear structure in the 
nucleus that is primarily responsible for the generation of ribosomal RNAs (Németh and 
Längst 2011). Recently, genome-wide mapping has revealed that all human chromosomes 
have NADs located at unique loci as well as at repetitive sequences (van Koningsbruggen 
et al. 2010; Németh and Längst 2011). NADs share common features of low gene density, 
low transcriptional activity and high AT-rich sequence elements density (van 
Koningsbruggen et al. 2010). Interestingly, following cell division, chromatin associated 
with NADs, either returned to the nucleolus or to the nuclear periphery, suggesting that 
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defined chromatin regions shuttle between the nuclear periphery and nucleolus depending 
on cell type or cell cycle (van Koningsbruggen et al. 2010; Kind et al. 2013).   
1.3.5 Lamin Associated Domains 
In general, higher order chromatin organization in the nucleus positions chromatin to the 
nuclear periphery, where genes are generally silenced or in the nuclear interior where genes 
are typically active. At the nuclear periphery resides the nuclear lamina, an architectural 
framework that links chromatin to the inner nuclear membrane (Gruenbaum et al. 2003). 
Lamin associated domains (LADs) are regions of chromatin that are bound to Lamin B1, a 
major component of the nuclear lamina (Figure 1-4), and frequently span ~1 Mb in size 
(Guelen et al. 2008). There is a close association of LADs with chromatin possessing low 
to no transcription. Mapping of LADs has shown that as much as 30% to 40% of the mouse 
and human genomes reside in LADs, respectively (Guelen et al. 2008; Wu and Yao 2013). 
Unlike TADs that remain largely stable across cell and tissue types, LADs appear to fall 
into two groups, constitutive LADs and dynamic LADs. Constitutive LADs are stable 
across multiple undifferentiated and differentiated cell types and account for ~33% of the 
mouse genome, while dynamic LADs with distinct patterns depending on cell type 
represent ~29% of the genome (Meuleman et al. 2013). Generally, inactive genes within a 
dynamic LAD in one cell-type will move away from the nuclear periphery to become 
activated in another cell-type (Peric-Hupkes et al. 2010). In total, over 60% of chromatin 
within the genome is constituted by LADs (Meuleman et al. 2013).  LADs are characterized 
by the repressive histone modification H3K9me2 and H3K27me3.  H3K9me2 is catalyzed 
by the histone methyltransferase G9a (Wen et al. 2009). One role identified for G9a-
dependent H3K9me2 is to help tether chromatin to the lamina, supporting the nuclear 
periphery association of LADs (Kind et al. 2013). By comparison, H3K27me3 is mostly 
excluded from the interior of LADs, instead demarcating LAD borders (Wen et al. 2009). 
These LADs borders typically interface with chromatin boundaries where lamin 
association markedly declines, and CTCF binding sites together with CpG islands are 
enriched (Guelen et al. 2008). In addition to Lamin B1, other components of the nuclear 
lamina are important for maintaining chromatin association with the nuclear matrix and 
gene silencing, including Lamin A/C (Harr et al. 2015) and the Lamin B receptor 
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(Polioudaki et al. 2001; Guarda et al. 2009). In a two-step process, Lamin A/C followed by 
Lamin B receptor tethers heterochromatin to the nuclear matrix (Namekawa et al. 2010; 
Solovei et al. 2013). Loss of both proteins relocates heterochromatin from the nuclear 
periphery into the nuclear interior. 
1.3.6 Nuclear pore complex 
The nuclear membrane, which encases the genetic material of the cell, is studded with 
numerous large aqueous transport channels called nuclear pore complexes (NPCs). Each 
NPC is made up of 30 different proteins termed as nucleoporins (Tran and Wente, 2006). 
The NPC is one of the largest macromolecules in the cell with an average molecular mass 
of 60-90 MDa (Rout et. al., 2000). The major components of the central scaffold of the 
NPC include the core scaffold NUP107-160 subcomplex, the inner ring (includes NUP98) 
and the central channel NUP62 complex (Figure 1-5). The NUP107-160 subcomplex is 
located on both nuclear and cytoplasmic sides as rings. On one side of the central scaffold 
are the cytoplasmic fibers, which include NUP358 and NUP214. On the nucleoplasmic 
side, NUP153, NUP50 and TPR form eight filament extensions and the distal ring, known 
as the nuclear basket. The fiber extensions on both sides create a permeability barrier, 
acting as gates for controlled import and export of macromolecules larger than 5 nm/40 
kDA (Hullsman et. al. 2012, Mohr et. al. 2009). Molecules measuring less than 5 nm or 
smaller than 40 kDA can diffuse freely between the nucleus and cytoplasm.  
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Figure 1—5: Structure of the nuclear pore complex 
The Nuclear Pore Complex (NPC) consists of 30 nucleoporin proteins arranged in an 
octahedral formation. The key structural components of the nuclear pore complex are the 
central scaffold, which consists of central channel NUP62 complex, the inner ring (includes 
NUP98) and the core scaffold NUP107-160 subcomplex. On either sides of the central 
scaffold are the cytoplasmic fibers, which include NUP358 (not shown) and NUP214, and 
the nuclear basket, which includes NUP153, NUP50 (not shown) and TPR (not shown). 
Arrows through the central scaffold indicate nuclear import and export. 
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1.3.6.1 Nucleoporin Associated Chromatin 
One key function of NPCs is transport of cellular material between the cytoplasm and 
nucleus (Hoelz et al., 2011). In recent years, it has become apparent that nuclear transport 
is not the sole function of the NPC. Studies in mammalian cells, yeast and Drosophila have 
identified a role for NPCs in gene regulation, including chromosome organization, 
chromatin loop formation, chromatin boundary formation, and prevention of 
heterochromatin spreading into euchromatic regions (Figure 1-4) (Ishii et al. 2002; 
Dilworth et al. 2005; Capelson et al., 2010; Mendjan et al., 2006; Vaquerizas et al., 2010). 
In mammals, NUP107, NUP62, NUP98 and NUP153 have been identified as chromatin-
interacting nucleoporins. NUP107-160 and NUP62 complex proteins also associate with 
spindles and kinetochores (Favreau et al., 1996), where they play a role in relocating and/or 
reorganizing chromatin upon nuclear membrane reformation at the end of mitosis 
(Kalverda et al., 2010). NUP98 plays a role during human embryonic stem (ES) cells 
differentiation to neural progenitor cells, altering chromatin structure to an active state with 
different binding targets in each cell type (Light et al. 2013). For example, induction with 
interferon gamma results in NUP98-dependent target gene activation accompanied by 
H3K4me2 and RNAPII enrichment at target gene promoters. NUP153 has documented 
roles in gene activation and repression. For example, in Drosophila NUP153 interacts with 
the dosage compensation complex for two-fold hyperactivation of the male X chromosome 
(Mendjan et. al., 2006). In mouse ES cells, NUP153 binds to and represses key 
developmental genes. Upon Nup153 depletion, these genes are reactivated, promoting 
differentiation (Jacinto et. al., 2015). Further studies are required to determine the precise 
function of nucleoporins in the regulation of gene expression as well as the organization of 
chromatin domains.  
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1.4 Genomic imprinting 
Genomic imprinting is an epigenetic process that restricts expression of specific genes to 
the maternally or paternally inherited allele; whereas the opposite parental copy is silent 
(Figure 1-6). The first evidence of genomic imprinting in mouse came from nuclear 
transplantations (Barton et al., 1984; McGrath and Solter, 1983; McGrath and Solter, 1984; 
Surani et al., 1984). Embryos generated using two female pronuclei (gynogenetic embryos) 
exhibit normal embryonic development, but are defective in extraembryonic tissue 
development, whereas embryos generated using two male pronuclei (androgenetic 
embryos) have well-developed extraembryonic tissues but are defective in embryonic 
tissue development. These results indicate that both the maternal and paternal genomes are 
essential for development of the embryo and that the two parental genomes are not 
functional equivalents, expressing different set of genes.  Currently, over 100 genes in mice 
and humans are known to be regulated by genomic imprinting (Bartolomei and Ferguson-
Smith 2011). Often, these imprinted genes are located within imprinted domains that are 
controlled from a single germline differentially methylated region (gDMR). gDMRs reside 
within CG dinucleotide dense regions, known as CpG islands. Imprinted domains can 
range in size from single retrotransposed gene to large regions spanning up to ~3 Mb. In 
the mouse, 21 maternal and 3 paternal gDMRs have been identified. Imprinted gDMRs are 
referred to as imprinting control regions (ICRs) if gDMR deletion results in a domain-wide 
loss of imprinting (Spahn and Barlow 2003).  Parental-specific DNA methylation of 
gDMRs/ICRs is established in the germline and maintained during preimplantation 
development (MacDonald and Mann 2014). Histone modification are also associated with 
gDMRs/ICRs, including the repressive marks, H3K9me3, H3K27me3 and H4K20me3, 
and active modifications, such as H3K4me2/3 (McEwen and Ferguson-Smith 2010). Thus, 
imprinted domains have bivalent chromatin, with the unmethylated gDMR possessing 
active euchromatic epigenetic modifications, while the silent methylated gDMR bears 
repressive epigenetic modifications of heterochromatin. Overall, an intriguing aspect of 
imprinted domains is how the allelic duality of chromatin states is regulated.  
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Figure 1—6: Representation of imprinted genes 
Biallelic expression from maternal and paternal alleles is a common characteristic for most 
genes within the genome. A small subset of genes display monoallelic parental-specific 
expression. They are either expressed from the maternal allele (red) and are paternally 
silent (grey), or are expressed from the paternal allele (blue) and are maternally silent 
(grey). This monoallelic expression may be due to repressive histone modifications or 
DNA methylation at the promoters of these genes only on the silent parental allele, while 
the active allele exhibits active histone modifications and no DNA methylation.  
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Long noncoding RNAs are a key feature of imprinted domains and play a key role in 
regulating imprinted expression along with higher order chromatin structure. Imprinted 
long ncRNAs range in length from ~1.6 kb to ~1000 kb, and thus, many imprinted long 
ncRNAs are also classified as macro ncRNAs due to their extraordinary length (Guenzl 
and Barlow 2012). Generally, long ncRNAs are associated with gene repression. To date, 
seven long ncRNAs have been identified that are regulated by imprinted gDMRs and are 
conserved between mice and humans; Airn, Gtl2, H19, Kcnq1ot1, Nespas, Peg13, and 
Ube3a-as (Brannan et al. 1990; Gray et al. 1999; Smilinich et al. 1999; Lyle et al. 2000; 
Paulsen et al. 2001; Coombes et al. 2003; Court et al. 2014). The proposed mechanisms 
by which ncRNAs act on imprinted domain include transcription interference, coating of 
the domain, and ncRNA-mediated silencing. 
 
Currently, there are two models of imprinted domain regulation. The first is an ICR-
mediated enhancer-blocking mechanism. The second is through a ncRNA-mediated 
mechanism. Two domains are presented as models below, the H19 domain and the Airn 
domain.  
1.4.1 H19 domain 
The H19 domain is a well-characterized example of an ICR-mediated enhancer-blocking 
mechanism. The H19 imprinted domain contains the paternally methylated ICR, two 
paternally methylated secondary somatic DMRs [DMR1 proximal to insulin-like growth 
factor 2 (Igf2) and DMR2 within Igf2], the maternally-expressed H19 long ncRNA gene, 
the paternally-expressed protein-coding genes, Igf2 and insulin II (Ins2), and the insulin-
like growth factor 2 antisense (Igf2as) gene (Constancia et al. 2000; Murrell et al. 2001) 
(Figure 1-7). The H19 ncRNA is 2.3 kb in length. On the maternal allele, CTCF binds the 
unmethylated ICR, acting as an enhancer blocker, that directs maternal expression of H19 
(Lopes et al. 2003; Fedoriw et al. 2004), and maintains the maternal ICR in an 
unmethylated state (Schoenherr et al. 2003). Together with cohesin, CTCF mediates 
chromatin looping such that the maternal ICR interacts with DMR1 to isolate Igf2 and Ins2 
away from the enhancers, and protects somatic DMRs from becoming methylated on the 
maternal allele (Figure 1-8) (Lopes et al. 2003; Yoon et al. 2007; Li et al. 2008a; Nativio 
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et al. 2009). On the paternal allele, DNA methylation prevents CTCF binding the H19 ICR, 
leading to paternal expression of Igf2 and Ins2 (Leighton et al. 1995; Kurukuti et al. 2006; 
Yoon et al. 2007).  
The H19 ICR is critical for mediating parental-specific chromatin loops and enhancer 
insulator function. Maternal inheritance of a H19 ICR deletion results in a loss of insulator 
function and biallelic Igf2 and Ins2 expression, while paternal inheritance of a H19 ICR 
deletion results in biallelic H19 expression and reduced Igf2 expression (Leighton et al. 
1995; Thorvaldsen et al. 1998). Targeted deletion of CTCF binding sites and point 
mutations within the maternal H19 ICR abrogates CTCF binding, leads to a loss in H19 
expression, as well as activation of the normally silent maternal Igf2 allele (Engel et al., 
2006; Pant et al., 2003; Pant et al., 2004). However, CTCF depletion did not yield changes 
to imprinted regulation of the H19 ncRNA (Lin et al. 2011). Furthermore, depletion of 
cohesin proteins in mouse embryonic fibroblasts resulted in increased Igf2 expression, yet 
Igf2 remained paternally expressed, suggesting that additional mechanisms beyond 
chromatin looping are required for the regulation of allelic expression (Lin et al. 2011). In 
humans, chromatin topology changes occur at the H19 imprinted domain in Beckwith-
Wiedemann Syndrome and Silver-Russell Syndrome patients with imprinting errors 
(Nativio et al. 2011). Beckwith-Wiedemann Syndrome patients with a gain of maternal 
H19 ICR DNA methylation have altered chromatin looping, bringing the downstream 
enhancer into proximity with the maternal Igf2 gene, while Silver-Russell Syndrome 
patients with a loss of paternal H19 ICR DNA methylation have a chromatin loop that 
sequesters the downstream enhancer away from paternal Igf2 and into proximity with H19 
(Nativio et al. 2011). Such alterations to chromatin looping are likely the consequence of 
subtopological changes. 
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Figure 1—7: Structure and regulation of the H19 imprinted domain 
The H19 domain is located on the mouse chromosome 7 and is a well-studied example of 
the ICR-mediated enhancer-block mechanism. On the maternal allele, the ICR is 
unmethylated (open circles), allowing the enhancers (E, enhancer). to access the H19 
promoter, enabling H19 ncRNA is expressed. CTCF blocks the enhancers from accessing 
the Igf2 and Ins2 genes. On the paternal allele, the H19 ICR is methylated (closed circles), 
inhibiting CTCF binding, thereby silencing paternal H19 expression. The enhancers can 
now access the Igf2 and Ins2 promoters, activating these genes. DMR1 acts a silencer while 
DMR2 is an enhancer that is activated upon methylation. Igf2 and Ins2 are expressed.  
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Figure 1—8: ICR-mediated enhancer-blocking model for the H19 imprinted domain 
On the maternal allele, CTCF binds to the unmethylated ICR and DMR2, thereby 
generating a loop that prevents Igf2 from interacting with the downstream enhancer. This 
loop brings the enhancers in close proximity to the H19 promoter, promoting H19. On the 
paternal allele, CTCF is unable to bind to the methylated H19 ICR, allowing Igf2 and Ins2 
to interact with the downstream enhancer, enabling their expression.  
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1.4.2 Airn domain 
The antisense to Igf2 receptor ncRNA domain (Airn) imprinted domain is localized on 
mouse chromosome 17 and serves as an example of noncoding RNA-mediated silencing. 
The Airn domain consists of a maternally methylated ICR, paternally expressed 118 kb 
Airn macro ncRNA and maternally expressed protein-coding genes which include insulin-
like growth factor 2 receptor (Igf2r), solute carrier family 22, member 2 (Slc22a2) and 
solute carrier family 22, member 3 (Slc22a3) (Figure 1-9). The Airn ICR is located in intron 
2 of the Igf2r gene. On the maternal allele, the Airn ICR is methylated, repressing Airn 
transcription, and Igf2r, Slc22a2 and Slc22a3 are expressed. On the paternal allele, the Airn 
ICR is unmethylated, and the Airn ncRNA is expressed. Airn is transcribed antisense to 
Igf2r through its promoter, thereby interfering with RNA polymerase II binding (Stricker 
2008) and silencing Igf2r in the embryo and placenta. Slc22a2 and Slc22a3 are positioned 
upstream of of Airn. Airn coats the domain and recruits silencing factors, repressing 
Slc22a2 and Slc22a3 transcription in the placenta. Paternal deletion of the Airn ICR, 
including the embedded Airn promoter, results in paternal allelic reactivation of the three 
imprinted genes (Sleutels et al., 2002). Similarly, truncation of the paternal Airn transcript 
by insertion of a polyadenylation signal results in reactivates the paternal Igf2r, Slc22a2 
and Slc22a3 alleles, pointing to the requirement of the Airn ncRNA in mediating silencing 
(Sleutels et al., 2002). Three mechanisms have been proposed for Airn ncRNA function. 
First, Airn transcription through the Igf2r promoter interferes with Igf2r transcription. 
Second, Airn coats the paternal allele, promoting heterochromatin formation. Lastly, the 
Airn ncRNA act as adaptors to recruit silencing factors, inducing repression of 
neighbouring genes. Biotin-based labeling and purification studies have shown that Airn 
interacts with the paternal Slc22a3 promoter, hundreds of kilobases away from the Airn 
transcription start site, and further recruits G9a, a histone H3K9 methyltransferase to the 
paternal Slc22a3 promoter, thereby silencing upstream genes (Nagano et al., 2008).  Thus, 
all three mechanisms for the Airn ncRNA may be operating at this domain. 
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Figure 1—9: Structure of the Airn imprinted domain 
Schematic representation of the Airn domain in mouse. On the paternal allele, the Airn ICR 
is unmethylated, allowing expression of the Airn ncRNA (blue wavy arrow), which results 
in neighbouring protein-coding gene silencing (black boxes). On the maternal, the Airn 
ICR is methylated, silencing the embedded Airn promoter and its transcription, and thereby 
permitting maternal expression of Ig2r, Slc22a2 and Slc22a3. Igf2r is maternally expressed 
in the embryo and placenta, while Slc22a2 and Slc22a3 are maternally expressed only in 
placenta and are biallelic expressed in the embryo. Arrows indicate direction of 
transcription.  
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1.4.3 Kcnq1ot1 imprinted domain 
The Kcnq1ot1 imprinted domain spans a 1 Mb-region in mice and is characterized by a 
maternally methylated ICR (also known as the KvDMR), paternally expressed Kcnq1ot1 
(Kcnq1 opposite transcript 1) long ncRNA, nine maternally expressed protein-coding 
genes and five genes that escape imprinted regulation (Figure 1-10) (Paulsen et al., 1998; 
Smilinich et al., 1999; Umlauf et al., 2004). The maternally expressed, protein-coding 
genes within this domain include oxysterol binding protein-like 5 (Osbpl5), pleckstrin 
homology-like domain, family A, member 2 (Phlda2), solute carrier family 22, member 18 
(Slc22a18), cyclin-dependent kinase inhibitor 1C (Cdkn1c), potassium voltage-gated 
channel, subfamily Q, member 1 (Kcnq1), tumor-suppressing subchromosomal 
transferable fragment 4 (Tssc4), CD81 antigen (Cd81), achaete-scute complex homolog 2 
(Ascl2) and tyrosine hydroxylase (Th). On the maternal allele, the Kcnq1ot1 ICR is 
methylated, silencing the embedded Kcnq1ot1 promoter and its transcription, and thereby 
permitting expression of neighbouring genes. On the paternal allele, the Kcnq1ot1 ICR is 
unmethylated, allowing Kcnq1ot1 ncRNA transcription, which results in neighbouring 
protein-coding gene silencing. Paternal inheritance of Kcnq1ot1 ICR deletions lead to 
paternal reactivation of imprinted genes within the domain (Fitzpatrick et al., 2002; 
Mancini-Dinardo et al., 2006). Similarly, paternal transmission of a Kcnq1ot1 truncation, 
which was generated by insertion of a polyadenylation site 2.6 kb from the transcription 
start site, leaving the Kcnq1ot1 ICR intact, results in paternal allelic reactivation (Shin et 
al., 2008). However, when the deletions or truncation are maternally transmitted, there is 
no effect on Kcnq1ot1 domain regulation (Fitzpatrick et al., 2002; Mancini-Dinardo et al., 
2006; Shin et al., 2008). These results suggest that elements within the ICR and the 
Kcnq1ot1 ncRNA and/or its transcription are essential for paternal allelic silencing of 
imprinted genes within the Kcnq1ot1 domain. Consistent with its DNA methylated status, 
the maternal Kcnq1ot1 ICR also possesses repressive histone modifications (H3K9me2/3 
and H3K27me3) (Lewis et al., 2004). By comparison, the unmethylated paternal ICR, 
which harbours the active Kcnq1ot1 ncRNA promoter, is marked by H3K4me3. The 
paternally silent protein-coding genes also carry repressive histone modifications 
(H3K9me2/3 and H3K27me3).  
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A number of mechanisms have been proposed to regulate the Kcnq1ot1 imprinted domain. 
One mechanism, which is similar to the H19 domain, is the ICR-mediated enhancer 
blocking mechanism (Fitzpatrick et al., 2007; Lin et al., 2011). Using reporter assays, the 
Kcnq1ot1 ICR has been shown to act as an insulator when introduced between a promoter 
and enhancer for a gene (Mohammad et al., 2008). In addition, in an episomal system, a 
region within the Kcnq1ot1 ICR has been identified to have silencer activity, 
bidirectionally repressing adjacent genes in a position independent manner. Point 
mutations in this minimal repressive region result in loss of bidirectional silencing 
(Kanduri et al., 2002; Thakur et al., 2003; Thakur et al., 2004). At the paternal Kcnq1ot1 
domain, CTCF binds to the unmethylated Kcnq1ot1 ICR at two CTCF recognition sites, 
thereby restricting access of the enhancer element to upstream genes, for example Cdkn1c, 
thereby inducing their silencing (Fitzpatrick et al., 2007; Lin et al., 2011; Shin et al., 2008). 
However, it is unknown if this enhancer functions to promote Kcnq1ot1 expression 
(Fitzpatrick et al., 2007). In contrast, other studies have found that CTCF binding occurs 
at both the maternal and paternal Kcnq1ot1 ICRs and is dispensable for enhancer-blocking 
mechanisms (Lin et al., 2011). Similar to the Airn domain, a second model proposes that 
the Kcnq1ot1 ncRNA has the ability to interact, bind and recruit various polycomb 
repressive complex proteins to chromatin within the domain, thereby inducing silencing 
via repressive histone modifications (Mancini-Dinardo et al., 2006). In support of this, the 
Kcnq1ot1 ncRNA has been reported to interact with promoters of the imprinted genes 
within the domain, leading to the incorporation of repressive histone modifications (Pandey 
et al., 2008). Several epigenetic factors, including the polycomb repressive complex 2, 
histone methyltransferase G9a, and DNA methyltransferase 1, have been shown to interact 
with Kcnq1ot1 ncRNA (Kaneko et al., 2014; Mohammad et al., 2008; Pandey, 2008; 
Terranova et al., 2008; Zhao et al., 2010). Finally, it has been proposed that active 
transcription of the Kcnq1ot1 gene leads to paternal allelic silencing of neighboring genes 
in the domain rather than the Kcnq1ot1 transcript itself (Golding et al., 2011). In the case 
of all three proposed mechanisms, it is still unclear how the Kcnq1ot1 ICR performs its 
function and how the Kcnq1ot1 domain is fully regulated.  
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Figure 1—10: Structure of the Kcnq1ot1 imprinted domain 
Schematic representation of the Kcnq1ot1 domain in mouse. On the paternal allele, the 
Kcnq1ot1 ICR is unmethylated, allowing expression of the Kcnq1ot1 ncRNA, which 
results in neighbouring protein-coding gene silencing. On the maternal allele, Kcnq1ot1 
ICR is methylated, silencing the embedded Kcnq1ot1 promoter and its transcription, and 
thereby permitting expression of neighbouring genes. Arrows indicate the direction of 
transcription. 
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1.4.3.1 Tissue-specific regulation of the Kcnq1ot1 domain 
One characteristic of imprinted genes is that they display tissue-specific and developmental 
stage-specific imprinted expression. The Kcnq1ot1 domain exhibits both tissue-specific 
and developmental stage-specific regulation. Between embryonic and extraembryonic 
lineages, there is a clear difference between imprinted regulation of the protein-coding 
genes. At the Kcnq1ot1 domain, genes are classified by their expression during mid-
gestation development as inner/ubiquitously imprinted genes (i.e. imprinted expression in 
embryonic and placental tissue), Phlda2, Slc22a18, Cdkn1c, Kcnq1 and Kcnq1ot1, and 
outer placental-specific imprinted genes, Osbpl5, Nap1l4, Tssc4, Cd81, Ascl2 and Th 
(Lewis et al. 2004; Umlauf et al. 2004; Golding et al. 2011; Mohammad et al. 2012). 
Several mechanism have been identified that may account for this differential tissue-
specific regulation. In the placenta, the Kcnq1ot1 long ncRNA transcript interact with the 
polycomb complex PRC2 and histone methyltransferase G9a (Pandey et al. 2008). This 
interaction is not observed in embryonic liver. Furthermore, in the placenta, the Kcnq1ot1 
long ncRNA interacts with the Osbpl5, Cdkn1c, Kcnq1, Cd81 and Ascl2 promoters, 
providing a functional role in directing the repressive epigenetic marks H3K27me3 and 
H3K9me2 to paternally silent genes (Pandey et al. 2008; Terranova 2008; Umlauf 2004). 
Interestingly, on a Dnmt1-deficient background, the maternal Kcnq1ot1 ICR becomes 
unmethylated (Lewis 2004; Tanaka 1999), resulting in reduced maternal expression as well 
as reactivation of paternal alleles of the Phlda2, Slc22a18, and Cdkn1c genes in the both 
placenta and embryo. By comparison, Osbpl5, Kcnq1, Tssc4, Cd81 and Ascl2 maintain 
maternal allelic expression and paternal allelic silencing, indicating that in the placenta, 
these genes are regulated in a DNA methylation-independent manner. Finally, the paternal 
Kcnq1ot1 domain is larger than the maternal Kcnq1ot1 domain (Redrup et al., 2009; 
Terranova et al., 2008). The size of paternal Kcnq1ot1 domain differs between lineages, 
such that in the placenta, the paternal Kcnq1ot1 domain is larger compared to the paternal 
Kcnq1ot1 domain in the embryo (Redrup et al., 2009). This is possibly due to the larger 
subset of genes with paternal allelic silencing in the placenta. All together, these data point 
to differential regulation of the Kcnq1ot1 domain in embryonic and extraembryonic 
lineages. Currently, it is unclear when embryonic and extraembryonic lineages acquired 
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differential imprinted domain regulation and how this differential regulation is regulated 
during early stages of development.  
During early development, three distinct cell lineages emerge, such that at the early 
blastocyst stage, there are epiblast precursor, trophectoderm and primitive endoderm cells 
(Figure 1-11). These cells will give rise to the fetus, placenta and yolk sac, respectively. 
Pluripotent stem cells can be derived from these three lineages to produce embryonic (ES), 
trophoblast (TS) and extraembryonic endoderm (XEN) stem cells (Figure 1-11). At this 
early developmental time point, XEN, ES and TS cells have distinct imprinted expression 
patterns for genes in the Kcnq1ot1 imprinted domain (Golding et al., 2011; Lewis et al., 
2004; Lewis et al., 2006; Terranova et al., 2008; Umlauf et al., 2004) (Figure 1-12). For 
example, Osbpl5 is maternally expressed in XEN cells, but biallelically expressed in ES 
and TS cells. These expression patterns suggest that the Kcnq1ot1 imprinted domain must 
be differential regulated even at the early stage of lineage differentiation. However, the 
mechanisms responsible for this differential imprinted expression between the three 
lineages are still not clear.   
 
  
29 
 
 
 
 
 
 
Figure 1—11: Derivation of ES, TS and XEN stem cells from a blastocyst 
The blastocyst is composed of three distinct cell lineages. Stem cells can be derived from 
these lineages, such that epiblast precursor cells (inner cell mass) gives rise to embryonic 
stem cells (ES), the trophectoderm lineage gives rise to trophoblast stem cells (TS) and the 
primitive endoderm gives rise to extraembryonic endoderm stem cells (XEN). ES, TS and 
XEN cells can be cultured in vitro and represent characteristic features of the lineage from 
which they are derived.   
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Figure 1—12: Schematic representation of Kcnq1ot1 domain in XEN, ES and TS 
cells 
Parental-specific expression patterns differ for genes in the Kcnq1ot1 domain in XEN, ES 
and TS cells. For example, Osbpl5 is maternally expressed in XEN cells, but biallelically 
expressed in ES and TS cells, while Acsl2 is maternally expressed in TS cells, but 
biallelically expressed in ES and XEN cells. Red boxes, maternal expression; blue boxes, 
paternal expression; black boxes, silent; green boxes, biallelic expression; light blue box, 
maternal biased expression with less than 30% expression from the paternal allele; blue 
wavy line represents the Kcnq1ot1 ncRNA; black circle, methylated CpGs; white circle, 
unmethylated CpGs.  
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1.5 Beckwith-Wiedemann Syndrome 
Perturbations in genomic imprinting can lead to imprinting defects that cause misregulation 
of imprinted domains and can lead to imprinting disorders (Plasschaert and Bartolomei, 
2014). One such disorder is Beckwith-Wiedemann Syndrome (BWS) which occurs at an 
incidence of 1 in 13,700 (Weksberg et al., 2001). BWS is characterized by macroglossia, 
neonatal hypoglycemia, abdominal wall defects, and postnatal growth above the ninetieth 
percentile (Weksberg et al., 2005). BWS result from genetic and epigenetic defects at the 
KCNQ1OT1 and H19 imprinting domains. Of these patients, 50% exhibit a loss of DNA 
methylation on the maternal KCNQ1OT1 ICR resulting in bialleic expression of the 
KCNQ1OT1 ncRNA along with silencing of maternal-expressed genes within the domain, 
including CDKN1C and KCNQ1. By comparison, 5% of BWS patients have a gain of 
methylation at the H19 ICR that results in loss of maternal H19 ncRNA expression and 
reactivation of the maternally silent IGF2 allele. Therefore, it is critical to understand the 
mechanisms that regulate imprinted domains, including at the Kcnq1ot1 domain. 
 
1.6 Functional screen for epigenetic factors regulating 
the Kcnq1ot1 domain 
To identify epigenetic factors that regulate imprinted domains, we performed a novel loss-
of-function, positive-selection, RNA interference screen using the Kcnq1ot1 imprinted 
domain as a model domain (Landschoot, 2014). For the screen, we used a short-hairpin 
RNA library for 250 epigenetic factors. XEN cells carrying a paternal-targeted mutation of 
the Cdkn1c gene, where exons 1 and 2 were replaced by the PGK-neomycin resistance 
cassette (Cdkn1c+/ΔneoR), were used for the screen (Zhang et al., 1997). Reactivation of the 
silent Cdkn1c+/ΔneoR allele following depletion of epigenetic factors allowed for survival 
and selection of colonies in the presence of neomycin. Thus, the screen was unbiased with 
respect to the type of epigenetic factors involved. In total, 41 different epigenetic factors 
were identified. The screen identified a few factors (PRC2 proteins, EZH2 and RNF2, 
histone 4 lysine 20 methyltransferase, SUV420H1, and DNMT1) that play a role in the 
Kcnq1ot1 domain regulation (Mohammad et al., 2010; Pandey et al., 2008; Pannetier et al., 
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2008; Terranova et al., 2008), which attests to the validity of the screen. However, they 
were recovered at a lower frequency than other candidates. Among of the top four 
candidates from the screen was nucleoporin 107 (NUP107). The role of nucleoporins in 
imprinted domain regulation is unknown. 
 
1.7 Rationale 
The mechanism by which the Kcnq1ot1 imprinted domain is regulated is poorly 
understood. More specifically, it is still unclear what regulates paternal Kcnq1ot1 ncRNA 
expression as well as paternal allelic silencing of the neighbouring protein-coding genes. 
Nucleoporin 107 was an exciting candidate that emerged from our screen. Currently, it is 
not known whether NUP107 and other chromatin-binding nucleoporins (NUP62, NUP98 
and NUP153) play a role in regulating the Kcnq1ot1 domain imprinting in XEN cells. 
Moreover, the mechanisms responsible for regulating the Kcnq1ot1 domain in the three 
lineages of the preimplantation embryo are poorly understood. ES, TS and XEN stem cells 
serve as an excellent model to study these three lineages. They are free from maternal 
contamination and allow us to perform genetic manipulations. The work presented here is 
the first investigation of nucleoporins as an epigenetic factor regulating the Kcnq1ot1 
imprinted domain. It is also the first to investigate whether nucleoporins have a role in 
regulating the Kcnq1ot1 imprinted domain in different lineages from the blastocyst stage 
embryo.  
1.8 Hypothesis 
I hypothesize that nucleoporins interact with the paternal Kcnq1ot1 ICR at the nuclear 
periphery allowing for Kcnq1ot1 ncRNA transcription. This in turn will enable silencing 
of neighbouring genes in the domain-wide manner in extraembryonic endoderm stem 
cells. Given that the imprinted genes within the Kcnq1ot1 domain exhibit differential 
paternal allelic silencing in embryonic, extraembryonic endoderm and trophoblast stem 
cells, I further hypothesize that nucleoporins will have different regulatory roles or may 
act on different sets of genes within the Kcnq1ot1 imprinted domain in ES, TS and XEN 
cells. 
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1.8.1 Objectives 
1. Determine whether NUP107 and other nucleoporins regulate imprinting at the 
Kcnq1ot1 domain in extraembryonic endoderm stem cells 
 
2. Determine the role of nucleoporins in regulation of imprinting at the Kcnq1ot1 
domain in embryonic and trophoblast stem cells. 
 
For both objectives, I will determine whether NUP107 as well as other NUPs 
a. regulate paternal Kcnq1ot1 ncRNA expression.  
b. play a role in Kcnq1ot1 domain positioning at the nuclear periphery.  
c. bind within the Kcnq1ot1 domain. 
d. regulate paternal allelic silencing of imprinted genes within the Kcnq1ot1 
domain.  
e. regulate the DNA methylation status of the Kcnq1ot1 ICR and histone 
modifications at the Kcnq1ot1 ICR and promoters of imprinted genes.  
f. interact with CTCF and cohesin proteins at the Kcnq1ot1 domain. 
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Chapter 2  
2  Methods  
2.1 Cell culture, treatments, transfection and transduction 
B6XCAST XEN, ES and TS cells were generated and cultured as described (Golding et 
al., 2010). XEN, ES and TS cells were cultured on a gelatin-coated feeder-free environment 
prior to experiments to avoid feeder contamination (Golding et al., 2011). For biological 
replicates, ES, TS and XEN cells derived from different embryos were used. Three 
technical replicates from each sample were performed. Where specified, cells were 
synchronized in G1 phase by treatment with 2 mM hydroxyurea (Sigma) followed by 
siRNA transfection. Cells were transfected with siRNAs using siPepMute (SignaGen). 
siRNA sequences are listed in Table 2-1. For nuclear import experiments, cells were 
transfected with E47-RFPNLS construct using Lipofectamine2000 (Invitrogen), followed by 
siRNA transfection. As a positive control, cells were treated with 10 µM of ivermectin 
(Sigma) for 48 hours. Recombinant lentiviral particles with shRNA targeting Luciferase 
with a green fluorescent protein (GFP) and puromycin resistance gene were generated in 
HEK293 cells (Golding et al., 2010). Following transduction and successful rounds of 
selection with puromycin, GFP-positive XEN cell populations were collected. To assess 
growth rates, ~25 000 cells were seeded, and then transfected 12 hours later with siRNAs. 
Direct cell counts were performed every 12 hours using a hemacytometer (VWR). Three 
replicates each were performed for control and Nup-depleted cells.  
2.2 RNA Isolation, cDNA preparation and PCR amplification 
RNA was isolated using PureLink® RNA Mini Kit (Life Technologies) and QuickRNATM 
MicroPrep (Zymo Research) according to manufacturers’ instructions. Before cDNA 
preparation, total RNA was subjected to DNase I (Life Technologies) treatment as 
described (Golding et al., 2011). cDNA was prepared using ProtoScript® II Reverse 
Transcriptase (NEB) as per instructions with oligodT (Sigma) and Random Primers (Life 
Technologies). cDNA was treated with RNaseA (Sigma) after preparation to remove 
residual RNA. PCR was performed on C1000 and MJ Research Thermocyclers (BioRad). 
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2.3 Quantitative PCR analysis 
Quantitative (q) PCR was performed as described (Golding et al., 2011). Briefly, qPCR 
was performed using iQ SYBR Green Supermix (BioRad) and SensiFASTTM SYBR® No-
ROX Kit (Bioline) on a MJ Thermocycler Chromo4 Real-time PCR system. For gene 
expression analysis, data were analyzed using the ΔΔCT method (Schmittgen and Livak, 
2008). For ChIP-qPCR data analysis was performed as described (Kernohan et al., 2010). 
Table 2-3 lists primers, annealing temperatures and amplicon sizes. 
2.4 Allelic expression analysis 
Allelic expression analysis to differentiate between maternal (B6) and paternal (CAST) 
allele was performed by restriction digestion of PCR product followed by separation on an 
8% acrylamide (29:1, Bio-Shop) gel. Densitometry was performed to quantify band 
intensity using QuantityOne 1-D Analysis Software (BioRad). Parental allele-specific 
expression was determined as a percent of B6 or CAST expression relative to the total 
expression. Table 2-2 lists SNPs, enzymes and fragment sizes. 
2.5 RNA/DNA fluorescence in situ hybridization, 
immunocytochemistry and confocal microscopy 
Kcnq1ot1 RNA/DNA FISH probe was generated using fosmid Wl1-2505B3 in the Kcnq1 
intronic region (CHORI) using the BioPrime DNA labeling System (Invitrogen) with 
fluorescein-12-dUTP (Roche) and Biotin-12-dUTP (Roche) for RNA FISH, and Cy5-UTP 
(GE Healthcare) for DNA FISH as described (Golding et al., 2011). For RNA FISH, cells 
seeded on coverslips in 12-well plates were fixed, dehydrated followed by hybridization 
with RNA-FISH probes as described (Golding et al., 2011). Briefly, following overnight 
incubation at 37°C, coverslips were carefully washed in 4X saline-sodium citrate (SSC) 
and 2X SSC (Ambion) at 37°C for 5 minutes 3 times each. Coverslips were incubated with 
primary antibody in blocking buffer (20X SSC, 10% Tween-20, 10% Skim Milk) at 37°C 
for 1 hour in the dark, then washed 3 times with 4X SSC (37°C) with agitation. Next, 
coverslips were incubated with the secondary antibody in blocking buffer at 37°C in the 
dark for 1 hour, then washed 3 times with 4X SSC and 2 times with 2X SSC buffers at 
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37°C with continuous agitation, 5 minutes each. The final wash was done in 1X SSC for 5 
minutes. Coverslips were mounted on glass slides with Vectashield DAPI (antifade 
mounting medium, Vector labs, H-1000) and stored in the dark for a few hours or overnight 
at 4°C. For DNA/RNA FISH, DNA FISH was first performed as described (Korostowski 
et al., 2011) followed by RNA FISH. Biotin-labeled oligo-dT-50 (Life Technologies) was 
used for polyA-mRNA FISH. Coverslips were imaged using z-stacks on a FluoView 
FV1000 coupled to an IX81 motorized inverted system (Olympus). Fluorescence signal 
volume, nuclear periphery distance from the signal centroid and fluorescence levels were 
measured using Volocity (PerkinElmer) and ImageJ. Table 2-3 lists antibody dilutions. 
2.6 Bisulfite mutagenesis and sequencing 
Control and siRNA treated cells (20% confluent) were seeded on gelatin-coated 6-well 
dishes. Forty-eight hours after transfection, cells were washed once with 1X PBS (Sigma) 
followed by a 5-minute incubation with 1X Trypsin-EDTA (Sigma) in PBS. Trypsin was 
inactivated by addition of RPMI medium. Detached cells were collected and pelleted 
gently, washed and re-suspended in 1X PBS. One percent of cells (~10,000 cells) were 
embedded into a 2:1 3% LMP agarose (Sigma) and lysis solution as described (Denomme 
et al., 2011). Bisulfite mutagenesis was performed as described for Kcnq1ot1 amplification 
in XEN cells (Denomme et al., 2011). For first round PCR amplification, the XEN cell 
agarose bead with bisulfite converted DNA (10 µL) was added to Hot Start Ready-To-Go 
PCR bead (GE Healthcare) containing 0.2 µM Kcnq1ot1 external primers, 9.6 ng/mL 
transfer RNA with a mineral oil overlay. First round PCR product (5 µL) was added to 
PCR beads containing 0.2 µM Kcnq1ot1 internal primers. See Table 2-2 for primers.  
2.7 RNA stability assay 
Kcnq1ot1 half-life studies were performed by addition of 2 µg/mL of actinomycin D 
(Sigma) to growth medium according to Hazan-Halevy et al. (2010) followed by collection 
at time-intervals up to 12 hours. RNA was extracted and cDNA was synthesized as 
described above. Kcnq1ot1 ncRNA levels were normalized to time 0 hours. 
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2.8 Chromatin Immunoprecipitation (ChIP) assay 
ChIP was performed as described with modifications for siRNA depletions (Kernohan et 
al., 2010). Equal numbers of cells were collected from control and siRNA treatment 
groups (~0.5-1.2 million cells). DNA extraction was performed using Chelex beads 
(BioRad). Table 2-3 lists antibody dilutions. Data are represented as total enrichment 
(percent input) or allelic enrichment (total enrichment x allelic enrichment ratio). 
2.9 Western Blot Analysis and Immunoprecipitation Assay 
Cytoplasm and nuclear protein extracts were isolated using cytoplasm extraction buffer 
and nuclear extraction buffer followed by Western blot analysis as described (Baldwin, 
1996; Golding et al., 2010). For list of antibodies and concentrations see Table S2. 
Protein immunoprecipitation was performed using Dynabeads Protein G (Novex, Life 
Technologies) as per manufacturers’ instructions. Immunoprecipitated protein samples 
were subjected to Western blot analysis. Antibodies that were used for Western blot 
analysis and IP assays are listed in Table 2-3. 
2.10 Biotin Immunoprecipitation Assay 
Biotin immunoprecipitation assay was performed as described (Hazan-Halevy et al., 2010) 
with modifications. Briefly, biotin-labeled DNA was incubated with nuclear lysate for two 
hours at 37°C. Nuclear lysate with biotin-labeled DNA was then incubated with 
streptavidin antibody (Abcam) conjugated beads (Invitrogen) at 4°C for three hours. 
Following washes, IP samples were mixed with Western blot loading buffer and subjected 
to Western blot analysis. See Table 2-3 for list of antibodies. 
2.11 Electromobility Shift Assay 
Electromobility shift assay was performed as per manufacturers’ instructions (LightShift™ 
Chemiluminescent EMSA Kit, ThermoFisher Scientific). Briefly, 20-30 µg of nuclear 
extracted protein was incubated with biotin-labeled DNA and specific antibodies (Table 2-
3) for 2 hours at 37°C. Antibody-protein-DNA complexes were resolved on a 8% non-
denaturing polyacrylamide gel, transferred onto a nylon membrane and then UV cross-
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linked. Shifts and super-shifts were determined using a streptavidin-horseradish peroxidase 
conjugate and LightShift chemiluminescent substrate. 
 
2.12 Statistical analysis 
For statistical analysis, one-tailed Student’s t-test was performed on mean values. 
Treatment samples were compared to control (Vehicle or siNT).  A p-value less than 0.05 
was considered to be significant. 
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Table 2—1: List of siRNA for depletion studies 
 
siRNA
Target Type Supplier Catalog
Concentrat
ion
Transfection 
Duration
Nup107-A SMARTpool ON-TARGETplus Dharmacon L-065221-01-0005 10 nmol 48 h
Nup62-A SMARTpool ON-TARGETplus Dharmacon L-064100-00-0005 10 nmol 48 h
Nup98-A SMARTpool ON-TARGETplus Dharmacon L-060137-01-0005 10 nmol 48 h
siNT-A SMARTpool ON-TARGETplus Dharmacon D-001810-01-20 10 nmol 48 h
Nup107-B1 Silencer Select siRNA Life Technologies s98083 10 nmol 48 h
Nup107-B2 Silencer Select siRNA Life Technologies s98085 10 nmol 48 h
Nup62-B1 Silencer Select siRNA Life Technologies s70887 10 nmol 48 h
Nup62-B2 Silencer Select siRNA Life Technologies s70885 10 nmol 48 h
Nup98-B1 Silencer Select siRNA Life Technologies s114479 10 nmol 48 h
Nup98-B2 Silencer Select siRNA Life Technologies s114477 10 nmol 48 h
Nup153-A Silencer Select siRNA Life Technologies s104224 10 nmol 48 h
Nup153-B Silencer Select siRNA Life Technologies s104225 10 nmol 48 h
siNT-B Silencer Select siRNA Life Technologies 4390847 10 nmol 48 h
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Table 2—2: Primer list 
  
 
Locus Primers Annealing Temp  (°C)
Amplicon
(bp)
SNP Enzyme 
[B6/CAST (bp)] Reference
Gene Expression
Osbpl5
F 5'CAGGGCAGCAGCAGAGGAT3'
57 415 AluI Golding et. al. 2011R 5'GGAGGTTGTTCTTCTCACACTCG3'
Phlda2
F 5'ATCCTTTGCGAGGGCGAGC3' 58 389 Hpy188III Golding et. al. 2011R 5'GCGTTTCACGGACCCAGA3'
Slc22a18
F 5'ATCAACAGGACTTTTGCCCC3' 56 257 SacII Golding et. al. 2011R 5'ATCAACAGGACTTTTGCCCC3'
Cdkn1c
F 5'GCCAATGCGAACGACTTC3' 58 364 Taq1 Golding et. al. 2011R 5'TACACCTTGGGACCAGCGTACTCC3'
Kcnq1ot1 F 5'GATCAGCATGGGTTATTGGA3' 60 213 HpaI Korostowski et. al. 
2012R 5'ATTAAGGGACCACAGCAAGG3'
Kcnq1
F 5'CATCGGTGCCCGTCTGAACAGG3' 58 189 NlaIII Golding et. al. 2011R 5'TTGCTGGGTAGGAAGAGCTCAG3'
Tssc4 F 5'AGAAGCTGCCCATCCTGAGT3' 58 262 AluI Lewis et. al. 2006R 5'GACCCACAATTCCCACAGTC3’
Cd81
F 5'GCGTCCTTGCTTCAAAGAGA3' 58 510 FauI Lewis et. al. 2006R 5'AGGCAAACAGGATCACAAGG3'
Th
F 5'CTTCCGTGTGTTTCAGTGC3' 57 195 BsrI Golding et. al. 2011R 5'ACCGTGGAGAGTTTTTCAA3'
GFP F 5'GTGACCACCCTGACCTACGG3' 56 150R 5'GATGTTGTGGCGAGGAGGATA3'
Nup62 F 5'ACCAGTGACCCATTGCAACA3' 58 240R 5'TCAACAACCAACCACGGGAA3'
Nup98 F 5'TACACCCAGCAGGCATTGTT3' 58 254R 5'TTCACCCACAGGTGGCTTTT3'
Nup107 F 5'CAGTCTGTGACACGTGGGAA3' 58 341R 5'GAGGTGTGTCATGAAGCGGA3'
Nup153 F 5’ GGGAGTGTCCAGTCTGCTGT3’ 58 167 Jacinto et. al. 2015R 5’ TCCCTCGGGCTTTTTAAACT3’
Chromatin Immunoprecipitation
Osbpl5 Promoter 1 (Os1) F 5'CCTTTCTCGGCCTTCCAC3' 60 152 AvaII
R 5'CCCTCTGGTATTTCCTGCTG3'
Osbpl5 Promoter 2 (Os2) F 5'AGCCAAAGGAGGGGAGGGTGG3' 60 296 DdeI
R 5'ATGGACCTGTGATCTTCTGGAA3'
Phlda2 Promoter 1 (Ph1) F 5'GGATGGAGTGGAAAAACAGCTCC3' 60 301 Hpy188III
R 5'GCCCGACTCCGGGGCGTGTCTG3 '
Phlda2 Promoter 2 (Ph2) F 5'CGATCTCCTTGTAATAGTTGGTGA3' 60 226 Hpy188III
R 5'GACGAGATCCTTTGCGAGGGCGA3'
Slc22a18 Promoter 1 (Sl1) F 5'GGACTCTGGACCCCAGGA 59 158 BsaJI
R 5'TTCCTCTGCCAAGAGGTTGT3'
Slc22a18 Promoter 2 (Sl2) F 5'GCTTCTCCTTAGGACCCCACTGG3' 61 188 HpyCH4III
R 5'GAGGAACAGGGAACCCTAGAACCTG3'
Kcnq1ot1 ICR1 (IC3) F 5'ATGATAGGCTGGATACAGATAG3' 60 249 BsaJI
R 5'GTACATTGGCTGCCTCAGGT3'
Kcnq1ot1 ICR2 (IC4) F 5'TCCCCAACAGAGACCTGAGCC3' 60 208 NlaIII
R 5'GTTTTCCGATGGTCTTAGGCG3'
Enhancer element 1 (E1) F 5'TTCAAACCATCTTTATGCTCCA3' 58 244 TspDTI
R 5'TGCCCTTAGCTCAAATCCAG3'
Enhancer element 2 (E2) F 5'AAAGGCTCAGGGAAGCTTTC3' 58 198 HindIIIR 5'TTTCCTTTCCCTGTGCTTGC3'
Kcnq1 Promoter 1 (Kc1) F 5'GATTTTCGCATTCTCCGCCG3' 58 202 SfaI
R 5'GCAGATACCACCACCACGAA3'
Kcnq1 Promoter 2 (Kc2) F 5'GCTCCTTCTGTGTCACTCTGG3' 58 265 AluI
R 5'GGACACTGAGCACCCTTGG3'
Tssc4 Promoter 1 (Ts1) F 5'ACCTGTTCCGTGCTTGGTT3' 57 284 AvaII
R 5'GCCTGTCTGTGCTTCCTGAC3'
Cd81 Promoter 1 (Cd1) F 5'CGCTTACTCTGGGACTGAGG3' 58 153 BfaIR 5'CGCCTAGCTCCTCACTCTTT3'
Th Promoter 1 (Th1) F 5'GGGTGGGCATAGTGCAAG3' 58 467 BslIR 5'CCTGGAGGGGACTTGAAGA3'
Control 1 (Ctrl1) F 5' TGGCATAGAACCTTCACAACACC3' 58 287 NlaIIIR 5'CAAATACAGAAGAGAATGCTCACAG 3'
Control 2 (Ctrl2) F 5'TCTTACAAAGTGCCTTGCTGACC3' 58 301 HindIIIR 5'ATTTCTGTGAGTGTGAGTCCAGC3'
Bisulfite mutagenesis
BIS Outer F 5'GTGTGATTTTATTTGGAGAG3' 52 571R 5'CCACTCACTACCTTAATACTAACCAC3'
BIS Inner F 5'GGTTAGAAGTAGAGGTGATT3' 52 228R5'TACTGAATTTCAAAACCACCCCTACTTGTAT3’
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Table 2-2: continued 
 
Gene Forward Primer Annealing Temperature
SNP 
Digestion 
Enzyme
Amplicon
(bp) Reference
Vim Promoter F 5' GGTTTCTTGTCCGACTTGCT 3' 58 MluCI 169R 5'CCTCCCCCTTTCTCTCTTTC 3'
Vim Exon 3 F 5' GCCTCTGCCAACCTTTTCTT 3' 58 183R 5' GGGGACTTTTGGGATAGCAT 3'
Vim 3'UTR F 5' CCTCCCAGTGATGACCAACT 3' 60 167R 5' GGAACTGAAGGGGTTTGCAG 3'
Orai2 Promoter F 5'GGTAGAGGCGTGCAAGAAAG 3' 60 MluCI 185R 5'TTCTCTGCCATCCATGAGGT 3'
Orai2 Exon 2 F 5' GTAAGCCCCAGTGTTCCTCT 3' 60 240R 5' GAGATCTGCCTCCTGAGTCC 3'
Orai2 3'UTR F 5' GTGCAGGAGGAGTTGAGAGT 3' 60 189R 5' GTGCAGGAGGAGTTGAGAGT 3'
Shank2 Promoter F 5' GAAGTCTACAGGGGACCTTCG 3' 60 BfaI 192R 5' TCCCACATAAGCCTGTCTCTG 3'
Shank2 Exon 4 F 5' TGGGAATGTCACTTCCTCCC 3' 60 179R 5'  ACCTAAGCCACGATTCCACA3'
Dhcr7 promoter F 5' GCCATTTGCTTGTCAGAGGT 3' 60 BfI 172R 5' CTGGAAGCAGACCAGTTGTG 3'
Dhcr7 Exon3 F 5' GAAAGGCAAGCTGTTTCCCA 3' 58 219R 5' TGGAATGAGCATGGGGTTCT 3'
Dhcr7 3'UTR F 5' AGTCTCTGCCAGTAACCCAC 3' 58 243R 5' TGCTGCGTGAGACTGAGTAA 3'
Kcnq1ot1 ICR1 F 5' GCCCAGGATTCATAAGCAAG3' 58 167R 5' GTTCACAGGACTGGCTCTCC 3'
Kcnq1ot1 ICR2 F 5' AAAAGCAATCCACCCTCTCA 3' 60 223R 5' GAGTGGCTGGGGTCTAACCT 3'
Kcnq1ot1 ICR5 F 5'ACAACAAAATGGAGGACTAAGGT 3' 58 169R 5' GGTTTTGAGTGTGAGCATAATGG 3'
Kcnq1ot1 ICR6 F 5' ACAAGAACAACAAAATGGAGGAC 3' 58 178F 5' GTTGGTTTTGAGTGTGAGCATAA 3'
Kcnq1ot1 ICR7 R 5' ACAGAAAAGGGAATGTGACCA 3' 58 183F 5' AGCATAATGGTCTGAGGTAGGG 3'
Kcnq1ot1 ICR8 R 5' GAAAGCACTCCTCCCCATTT 3' 60 199F 5' AATGGTCTGAGGTAGGGATCA 3'
Kcnq1ot1 ICR9 R 5' CCAGAAAGGTTACAGCGGAA 3' 60 155F 5' TCACATTTTGAGACATGGGGT 3'
Kcnq1ot1 ICR10 R 5' CAAAGGGCACACGGTATGAG 3' 60 175F 5'AAATGGGGAGGAGTGCTTTC 3'
Kcnq1ot1 ICR11 R 5' GGCAAGCTCTAGGGAACAGA 3' 60 197F 5' CTTTCTGGGCATAAAAGGGAGT 3'
Kcnq1ot1 ICR12 R 5' GGGGCAAGCTCTAGGGAAC 3' 60 196F 5' TCTGGGCATAAAAGGGAGTAAGT 3'
Kcnq1ot1 ICR13 R 5' TAATCCTGCCTGCCTGCTTT 3' 60 154F 5' CAATCTTTTCTCATACCGTGTGC 3'
Kcnq1ot1 ICR14 R 5' GTTAATCCTGCCTGCCTGC 3' 60 150F 5' TTTCTCATACCGTGTGCCCT 3'
Kcnq1ot1 ICR15 R 5' CCTTCATCTATGTTCACCAGGG 3' 60 130F 5' CTGTTTTGGGATTTGTGCTCC 3'
Enhancer element 3 R 5' CTGTCCATCTATCCCCGGTC 3' 60 193F 5' GGAGCATGAGTTGGAGGAGT 3'
Enhancer element 4 R 5' ACAGAGGAAGGCAAGTGTCA 3' 58 150F 5' GACCGGGGATAGATGGACAG 3'
Enhancer element 5 R 5' GACCCTCCCTGCACATTCTA 3' 58 161F 5' AACCAGCCTAGAATGTGCCT 3'
Enhancer element 6 R 5' GGGGCTCAGCTGTGTTTAAA 3' 56 194F 5' GAGGCCCAAACCAAACAGAG 3'
H19 ICR R 5' CAGGACTCAAAGGAACATGCTAC 3' 58 DpnII 398 Verona et. al. 2008F 5' GCAATCCGTTTTAGGACTGCG 3'
H19 exon5
R 5' GCACTAAGTCGATTGCACTGG3'
58 BgII 212
Verona et. al. 
2008
F 5'AACACTTTATGATGGAACTGC 3'
FoxA2 promoter R 5' TTTCAAGACATCCGGGCTAC 3' 58 279F 5' CACGAAATTGTGGACACCTG 3'
MyoD promoter R 5' TCCGCCCTACTACACTCCTA 3' 58 196
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Table 2—3: List of antibodies for Western blot analysis, Immunohistochemistry, 
RNA FISH, ChIP and IP. 
  
 
 
Antibody Catalogue Number Supplier
Concentration/
Dilution Duration Temp (°C)
Western
mAb414 - Nuclear Pore Complex ab24609 Abcam 1:1000 overnight 4
NUP98 ab50610 Abcam 1:1000 overnight 4
NUP107 ab73290 Abcam 1:1000 1 hr RT
NUP153 sc-101545 Santa Cruz Biotech 1: 1000 1 hr RT
H3 ab1791 Abcam 1:5000 1 hr RT
INCENP I5283 Sigma-Aldrich 1:10,000 1 hr RT
GFP G46-66M SignalChem 1:3000 overnight 4
SMC1 A300-055A Bethyl Laboratories 1:3000 overnight 4
SMC3 A300-060A Bethyl Laboratories 1:3000 overnight 4⍺-TUBULIN sc-8035 Santa Cruz Biotech 1:7000 1 hr RT
Anti-Mouse-HRP Secondary SC-2314 Santa Cruz Biotech 1:5000 1 hr RT
Anti-Rat-HRP Secondary SC-2956 Santa Cruz Biotech 1:4000 1 hr RT
Anti-Rabbit-HRP Secondary G33-62G SignalChem 1:6000 1 hr RT
Immunohistochemistry/RNA FISH
LaminB1 (S-20) sc-30264 Santa Cruz Biotech 1:1000 1 hr 37
Anti-Biotin ab1227 Abcam 1:1000 1 hr 37
Anti-Rabbit Alexa Fluor® 488 A-11034 Life Technologies 1:1000 1 hr 37
Anti-Goat Alexa Fluor® 594 A-11080 Life Technologies 1:1000 1 hr 37
Chromatin Immunoprecipitation / Immunoprecipitation
H3 ab1791 Abcam 2 µg overnight 4
H3K4me3 39159 Active Motif 3 µg overnight 4
H3K9me2 ab1220 Abcam 3 µg overnight 4
H3K27me3 07-449 Millipore 3 µg overnight 4
RNAPII sc-889 Millipore 3 µg 3 hr 4
mAb414 - Nuclear Pore Complex ab24609 Abcam 4 µg overnight 4
NUP153 sc-101545 Santa Cruz Biotech 4 µg overnight RT
SMC1 A300-055A Bethyl Laboratories 1.5 µg overnight 4
SMC3 A300-060A Bethyl Laboratories 1.5 µg overnight 4
Anti-Mouse IgG sc-2029 Santa Cruz Biotech * * *
Anti-Rabbit IgG 2729s Cell Signalling * * *
Anti-Goat IgG sc-2028 Santa Cruz Biotech * * *
* same as corresponding antibody used
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Chapter 3  
3  Results  
The mechanism by which the Kcnq1ot1 imprinted domain is regulated is poorly 
understood. More specifically, how paternal Kcnq1ot1 ncRNA expression and paternal 
allelic silencing of the neighbouring protein-coding genes are regulated. Nucleoporin 107 
was an exciting candidate that emerged from our screen.  Give that roles for nuclear pore 
complex proteins in gene regulation have been reported, I hypothesized that nucleoporins 
interact with the paternal Kcnq1ot1 ICR at the nuclear periphery, allowing for Kcnq1ot1 
ncRNA transcription. This in turn will enable silencing of neighbouring genes in the 
domain-wide manner in extraembryonic endoderm stem cells  
3.1 Nucleoporins regulate Kcnq1ot1 ncRNA expression in 
XEN cells 
NUP107 was investigated for its role in regulating imprinted gene regulation at the 
Kcnq1ot1 domain. In addition, to determine whether imprinted gene regulation was 
specific to NUP107, three additional nucleoporins, NUP62, NUP98 and NUP153, with 
documented chromatin association (Jacinto et al., 2015; Kalverda et al., 2010; Light et al., 
2013), were also investigated for their role in regulating the Kcnq1ot1 domain. Wildtype 
C57BL6 X Mus musculus castaneus (B6XCAST) XEN cells were transfected with two 
sets of Nup107, Nup62, Nup98/96 and Nup153 siRNAs to produce RNA and protein 
depletion (Figures 3-1), and cells were then assessed for total and allelic-specific Kcnq1ot1 
ncRNA expression. Compared to controls, Nup107, Nup62 and Nup153 depletion 
significantly reduced Kcnq1ot1 ncRNA levels to 0.25, 0.45 and 0.76 times, respectively 
(Figure 3-2A). By comparison, Nup98/96 depletion produced a 1.88 times increase in 
Kcnq1ot1 ncRNA levels. For all nucleoporin depletions, except for Nup153, the Kcnq1ot1 
ncRNA maintained paternal-specific expression, indicating that nucleoporin function is 
specific to the paternal allele (Figure 3-2B). Interestingly, for Nup153 depletion, the 
normally silent maternal Kcnq1ot1 ncRNA was reactivated (24%), suggesting that 
NUP153 functions on both parental alleles. 
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Figure 3—1: Nucleoporin depletion levels in XEN cells.  
(A) Nucleoporin RNA depletion levels. Quantitative real-time PCR analysis for Nup107, 
Nup62, Nup98/96 and Nup153 relative to Gapdh expression 48 hours after transfection. 
Transfections were performed using the two different sets of siRNAs (A and B; n=3). The 
Nup98 gene is a bicistronic gene that encodes for two separate nucleoporins, NUP98 and 
NUP96, from one mRNA. Since the siRNAs target the mRNA that will produce both 
proteins, the siRNAs have been designated si98/96. (B) Nucleoporin protein depletion 
levels. Western blot analysis for nucleoporins was performed 48 hours after transfection. 
The NUP98 antibody specifically recognized NUP98; no commercial antibody was 
available for NUP96.  Histone 3 (H3) was used as loading control. Transfections were 
performed using the two different sets of siRNAs (n=6). Error bars, s.e.m.; *, significance 
p < 0.05 compared to the WT control; Veh, vehicle; siNT, non-targeting siRNA; si107, 
Nup107 siRNA; si62, Nup62 siRNA; si98/96, Nup98/96 siRNA; si153, Nup153 siRNA.  
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3.2 Nucleoporins regulate Kcnq1ot1 ncRNA volume in XEN 
cells 
The Kcnq1ot1 ncRNA localizes to the nuclear compartment as a strong signal that overlaps 
the paternal Kcnq1ot1 domain (Fedoriw et al., 2012; Pandey et al., 2008; Redrup et al., 
2009). To determine whether reduced Kcnq1ot1 ncRNA abundance altered nuclear 
Kcnq1ot1 ncRNA volume, 3D RNA/DNA FISH for Kcnq1ot1 was performed on G1-
synchronized control and nucleoporin-depleted XEN cells, and Kcnq1ot1 ncRNA volume 
was calculated. Consistent with the expression analysis (Figure 3-2B), Kcnq1ot1 ncRNA 
localization was restricted to the paternal Kcnq1ot1 domain in control and Nup107-, 
Nup62- and Nup98-depleted XEN cells, while the Kcnq1ot1 ncRNA localized to both 
parental domains in Nup153-depleted XEN cells (Figure 3-2C,D). In controls, the majority 
of cells possessed medium Kcnq1ot1 ncRNA volumes (0.7-1.4 µm3, 74-76%), with a 
minority having volumes in low (<0.7 µm3, 7-10%), high (1.4-2.1 µm3, 15-17%) to very 
high (>2.1 µm3, 0-1%) ranges (Figure 3-2E). By comparison, Nup107, Nup62 and Nup153 
depletion generated a significant increase in percentage of cells, 78%, 69%, 26%, with low 
Kcnq1ot1 ncRNA volumes, respectively, while Nup98/96 depletion significantly increased 
the percentage of cells with high (39%) or very high (17%) volumes. In addition, upon 
Nup153 depletion, 75% of cells acquired low Kcnq1ot1 ncRNA volumes at the maternal 
Kcnq1ot1 domain, suggesting that NUP153 acts on both maternal and paternal alleles. To 
determine whether nucleoporins altered Kcnq1ot1 ncRNA stability, the Kcnq1ot1 ncRNA 
half-life was measured in control and Nup-depleted XEN cells after blocking transcription 
with actinomycin D. No difference in Kcnq1ot1 ncRNA half-life (5-6 hours) was found 
between control and Nup-depleted cells (Figure 3-3), indicating that alterations in 
Kcnq1ot1 ncRNA abundance and volume were unrelated to Kcnq1ot1 transcript stability. 
All together, these results demonstrate that nucleoporins facilitate paternal Kcnq1ot1 
ncRNA expression and localization at the Kcnq1ot1 domain. 
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Figure 3—2: Nucleoporin depletion disrupts Kcnq1ot1 ncRNA expression, domain 
volume and nuclear periphery localization.  
(A) Kcnq1ot1 ncRNA expression levels normalized to Gapdh. (B) Allelic Kcnq1ot1 
ncRNA expression in control and Nup-depleted XEN cells (n=4). (C) Representative 
confocal nuclear images displaying Kcnq1ot1 DNA (red), Kcnq1ot1 ncRNA (green) and 
DAPI staining (blue) for G1-synchronized control and Nup-depleted XEN cells (n=111); 
upper panel, DNA FISH; middle panel, RNA FISH; lower panel, merge; m, maternal 
domain; p, paternal domain. (D) Percent of cells with paternal or maternal Kcnq1ot1 
ncRNA signals. (E) Percent of cells with Kcnq1ot1 ncRNA signal volume; low, 0-0.7 µm3; 
medium, 0.7-1.4 µm3; high, 1.4-2.1 µm3; very high, >2.1 µm3. (F) Distance of the Kcnq1ot1 
ncRNA signal from the nuclear membrane in G1-synchronized control and Nup-depleted 
XEN cells; nuclear periphery, 0-0.5 µm; sub-nuclear periphery, 0.6-1.5 µm; nuclear 
interior, 1.6-4 µm; LAMINB1, red; Kcnq1ot1 ncRNA, green; DAPI, blue.  B6, maternal 
(red); CAST; paternal (blue); error bars, s.e.m; *, significance p < 0.05 compared to vehicle 
control; WT, wildtype; Veh, vehicle; siNT, non-targeting siRNA; si107, Nup107 siRNA; 
si62, Nup62 siRNA; si98/96, Nup98/96 siRNA, si153, Nup153 siRNA, scale bar, 1 µm. 
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Figure 3—3: Kcnq1ot1 ncRNA stability is not altered upon nucleoporin depletion. 
Control and Nup-depleted XEN cells were treated with actinomycin D for 1 hour, after 
which cells were collected up to 12 hours after release from treatment. Kcnq1ot1 
expression levels were normalized to 0 hours. No significant changes in Kcnq1ot1 
ncRNA levels were seen at different time intervals after treatment between samples 
compared to the WT control, indicating that there was no difference in Kcnq1ot1 ncRNA 
half-life in control and Nup-depleted XEN cells (n=3). WT, wildtype; Veh, vehicle; siNT, 
non-targeting siRNA; si107, Nup107 siRNA; si62, Nup62 siRNA; si98/96, Nup98/96 
siRNA, si153, Nup153 siRNA. 
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3.3 Nucleoporins regulate Kcnq1ot1 domain positioning in 
XEN cells 
Previous studies have shown that the Kcnq1ot1-coated domain is situated at the nuclear 
periphery, or perinucleolar region during S-phase (Fedoriw et. al. 2012; Pandey et. al., 
2008). To examine the position of the Kcnq1ot1-coated domain in XEN cells, DNA/RNA 
FISH was performed on G1-synchronized control and Nup-depleted XEN cells and the 
distance of the Kcnq1ot1 DNA centroid from the nuclear rim was calculated from confocal 
images (Figure 3-2F). Previous studies found that the distance between distal probes within 
the Kcnq1ot1 domain differed for the maternal and paternal alleles (Terranova et al. 2008; 
Redrup et al. 2009). Here, the maternal (0.1-0.8 µm3) and paternal (0.9-1.3 µm3) Kcnq1ot1 
domains were differentiated by domain volume using a centrally located probe (Figure 3-
4). In control cells, the Kcnq1ot1 ncRNA was stationed at the nuclear periphery (0-0.5 µm), 
sub-nuclear periphery (0.5-1.5 µm) and nuclear interior (> 1.5 µm) in 91-92%, 4-6% and 
3-4% of cells, respectively (Figure 3-2G). In Nup107-, Nup62 and Nup153-depleted XEN 
cells, nuclear periphery positioning of the Kcnq1ot1 ncRNA was significantly reduced to 
54%, 61% and 64% of the cells, shifting to sub-nuclear periphery and nuclear interior 
locales. Furthermore, in Nup153-depleted XEN cells, Kcnq1ot1 ncRNA positioning was 
similar for the paternal and maternal domains. Nup98/96 depletion also produced a 
significant shift in Kcnq1ot1 ncRNA nuclear peripheral (84%) positioning, albeit to a lesser 
extent than other nucleoporin depletions. Next, I examined the relationship between 
Kcnq1ot1 ncRNA volume and nuclear positioning. In control cells, the majority of cells 
had medium Kcnq1ot1 ncRNA volume that resided at the nuclear periphery. Nup107-, 
Nup62- and Nup153-depleted cells with low Kcnq1ot1 ncRNA volume shifted away from 
the nuclear periphery, while Nup98/96-depleted cells with increased ncRNA volumes 
primarily retained nuclear periphery positioning (Figure 3-5). By comparison, the maternal 
Kcnq1ot1 domain was randomly positioned within the nucleus. Upon Nup153 depletion, 
those cells with primarily low Kcnq1ot1 ncRNA expression had a shift in maternal 
Kcnq1ot1 domain positioning toward the nuclear periphery. These results indicate that 
NUP107, NUP62 and NUP153 are required to anchor the Kcnq1ot1-coated allele to the 
nuclear periphery. 
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Figure 3—4: Paternal and maternal Kcnq1ot1 domain have distinct volumes in XEN 
cells 
Paternal (blue, identified by Kcnq1ot1 ncRNA expression) and maternal (red) Kcnq1ot1 
domain volume were plotted on the Y-axis with the number of G1-synchronized control 
and Nup-depleted XEN cells plotted on the X-axis. Paternal Kcnq1ot1 DNA domain 
volume had a range of 0.9 to 1.3 µm3 while maternal Kcnq1ot1 DNA domain volume 
ranged from 0.1 to 0.8 µm3, except for the siNup153 treatment group, where the maternal 
Kcnq1ot1 DNA domain volume ranged from 0.14 to 1.1 µm3 (black bar, 0.85 µm3). For 
those cells with a maternal Kcnq1ot1 DNA domain volume greater than 0.9 µm3, the 
majority (92%) possessed an equal or larger paternal Kcnq1ot1 DNA domain volume; 
n=109-123.  
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Figure 3—5: Kcnq1ot1 ncRNA volume to distance correlation in control and 
nucleoporin-depleted XEN cells. 
Kcnq1ot1 ncRNA volume correlated with distance from nuclear periphery. Kcnq1ot1 
ncRNA volume and distance from nuclear periphery were plotted on X- and Y-axes, 
respectively, for G1-synchronized control and Nup-depleted XEN cells. Upon Nup107, 
Nup62 and Nup153 depletion, cells with low Kcnq1ot1 ncRNA volume shifted to sub-
nuclear peripheral and nuclear interior positions. The maternal Kcnq1ot1 domain was 
randomly positioned within the nucleus (expected NP 15%, SP 30%, NI 60%; observed 
NP 13-16%, 21-30; NI, 58-66), except for Nup153-depleted cells. Upon Nup153 depletion, 
those cells with maternal Kcnq1ot1 ncRNA expression (primarily low) had a shift in 
maternal Kcnq1ot1 domain positioning toward the nuclear periphery (NP 60%, SP 21%, 
NI, 19%). NP, Nuclear Periphery; SP, Sub-nuclear Periphery; NI, Nuclear Interior; Veh, 
vehicle; siNT, non-targeting siRNA; si107, Nup107 siRNA; si62, Nup62 siRNA; si98/96, 
Nup98/96 siRNA; si153, Nup153 siRNA; P, paternal; M, maternal; n=109-123.  
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3.4 Nucleoporins physically interact with the Kcnq1ot1 
domain in XEN cells 
I next investigated nucleoporin interactions with the Kcnq1ot1 imprinted domain. 
Quantitative chromatin immunoprecipitation (ChIP) was performed using the NUP107 
antibody (Figure 3-5A), the mAb414 antibody, which primarily interacts with NUP62, 
NUP107 and NUP160 (Figure 3-5B), and the NUP153 antibody (Figure 3-5C) in XEN 
cells; ChIP-grade NUP107 and NUP62 antibodies were not available. The identity of  
NUP107 and NUP62 following mAb414 IP were verified with the NUP107 antibody and 
in Nup62-depleted cells, respectively (Figure 3-5A). Antibodies were first validated at 
positive and neighbouring negative sites identified from mouse ES cells NUP153 DNA 
adenine methyltransferase identification (DamID) (Jacinto et al., 2015) (Figure 3-6A). Of 
the four NUP153 positive sites, Vim, Orai2, and Shank2 promoters displayed NUP153 
enrichment in XEN cells. mAb414 (NUP107/62) enrichment was observed at the Orai2 
and Shank2 promoters (Figure 3-6B). Curiously, Shank2, which resides upstream of the 
Kcnq1ot1 imprinted domain, showed preferential paternal mAb414 (NUP107/62) and 
NUP153 enrichment (Figure 3-6B). At the Kcnq1ot1 domain, 21 sites extending across the 
Kcnq1ot1 ICR to the reported H3K4me1-enriched enhancer elements (Korostowski et al., 
2011; Schultz et al., 2015), and 1-2 sites at imprinted gene promoters were assessed for 
total and allele-specific binding in WT XEN cells (Figure 3-6C, Figure 3-7A). Significant 
mAb414 (NUP107/62) enrichment was observed at 2 sites within the Kcnq1ot1 ICR (IC3, 
100 bp upstream, IC4, 1.7 kb downstream of the Kcnq1ot1 transcription start site), as well 
as at the Kcnq1ot1 enhancer element (E1 and E2) and the Osbpl5 promoter (Os1 and Os2) 
on the paternal allele (Figure 3-6C, Figure 3-7B,D). Significant NUP153 enrichment was 
also observed at the Kcnq1ot1 ICR (IC3, IC4), where both parental alleles were equally 
enriched, and at the paternal Kcnq1 (Kc1, Kc2) and Cd81 (Cd1) promoters (Figure 3-7C,E). 
Next, I investigated whether nucleoporin-chromatin interactions were lost upon Nup 
depletion. Since the mAb414 antibody recognizes both NUP62 and NUP107, double 
depletion was performed. I found a significant decrease in mAb414 (NUP107/62) 
occupancy at the Kcnq1ot1 ICR and putative enhancer element in double-depleted cells 
(Figure 3-7D). Upon Nup153 depletion, NUP153 binding on the paternal and maternal 
Kcnq1ot1 ICR, and the paternal Kcnq1 and Cd81 promoters was significantly reduced (Fig 
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3-7E). These results indicate that NUP107/NUP62 and NUP153 localize at the Kcnq1ot1 
domain. To determine whether there was interdependency between NUP107/62 and 
NUP153 binding, Nup153-depleted cells were examined for mAb414 enrichment, and 
Nup107- and Nup62-depleted cells were assessed for NUP153 enrichment. Nup153 
depletion significantly decreased mAb414 (NUP107/62) enrichment at the Kcnq1ot1 ICR 
region but not at the Osbpl5 promoter and enhancer sites (Figure 3-7F). Conversely, 
Nup107 and Nup62 depletion significantly decreased NUP153 enrichment at the Kcnq1ot1 
ICR and Kcnq1 promoter, while no change in enrichment was observed at the Cd81 
promoter (Figure 3-7G). These results indicate that nucleoporin interactions at the paternal 
Kcnq1ot1 ICR are cooperatively mediate through NUP107, NUP62 and NUP153. 
I further investigated whether nucleoporins can directly interact with Kcnq1ot1 ICR using 
biotin-labelled DNA fragments and nuclear lysates from control and Nup-depleted XEN 
cells. Electromobility shift assays were performed using the biotin-labelled Kcnq1ot1 ICR 
and control fragments (Figure 3-8A). Unlike the control fragment, supershifts were 
observed for the Kcnq1ot1 ICR fragment with mAb414 (NUP107/62), NUP107 and 
NUP153 antibodies, pointing to a direct interaction of these proteins with the Kcnq1ot1 
ICR. No supershift was produced using the NUP98 antibody. Next, reverse ChIP was 
performed to isolate proteins bound to a biotin-labelled Kcnq1ot1 ICR fragment containing 
the IC3 enrichment site, as well as a negative control fragment located 2-kb upstream of 
the Kcnq1ot1 ICR. This was followed by Western blot analysis using mAb414, NUP107, 
NUP98 and NUP153 antibodies. NUP107 bound to the Kcnq1ot1 ICR fragment but not the 
control fragment (Figure 3-8B). Nup107-depleted lysates abrogated NUP107 binding to 
levels observed for the control fragment. Furthermore, NUP62 (detected by the mAb414 
antibody) and NUP153 binding was also reduced, indicating that NUP62 and NUP153 
binding at the Kcnq1ot1 ICR required NUP107 binding. NUP153 also bound directly to 
the IC3-containing Kcnq1ot1 ICR fragment but not the control fragment. Upon Nup153 
depletion, binding was lost. However, NUP107 and NUP62 binding to the Kcnq1ot1 ICR 
fragment was not altered, perhaps indicating that there was sequential binding of 
NUP107/NUP62 and NUP153 in this in vitro system.  
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Figure 3—5: Antibody validation in XEN cells. 
(A) NUP107 IP was performed followed by Western blot analysis using the same NUP107 
antibody. (B) mAb414 IP was performed followed by Western blot analysis using the same 
mAb414 antibody. The most prominent nucleoporins detected with the mAb414 antibody 
in XEN cells were NUP62, NUP107 and NUP160. NUP62, NUP107 and NUP160 were 
identified by size. NUP107 identity was verified by mAb414 IP followed by Western blot 
analysis using the NUP107 antibody. NUP62 identity was verified using Nup62-depleted 
XEN cells. (C) NUP153 IP was performed followed by Western blot analysis using the 
same NUP153 antibody.  
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Figure 3—6: Antibody validation, and mAb414 and NUP153 enrichment at the 
Kcnq1ot1 ICR and enhancer element in XEN cells. 
(A) NUP153 enrichment regions were mapped from ES cell DamID-seq data (Jacinto et. 
al, 2015) at the Vim, Orai2 and Shank2 promoters (orange bar). These genes were not 
upregulated upon Nup153 depletion in ES cells and/or in ES cells differentiated into NeuP 
cells (Jacinto et. al, 2015). Positive sites within the enriched region as well as negative 
control sites within Vim, Orai2 and Shank2 exonic and 3’UTR sites (magenta bars) were 
selected for analysis in XEN cells. Additional negative control sites were selected from the 
Dhcr7 gene, which is located 80 kb upstream of the Osbpl5 gene. (B, C) NUP153 and 
mAb414 ChIP validation in XEN cells. NUP153 and mAb414 ChIP were performed at 
NUP153 positive sites, Vim, Orai2, Shank2 and Dhcr7 promoters, identified from ES cell 
data (Jacinto et. al, 2015), and at negative control Vim, Orai2, Shank2 and Dhcr7 exonic 
and 3’UTR sites. Significant NUP153 enrichment was observed at Vim, Orai2, Shank2, 
with mAb414 enrichment at Orai2 and Shank2 promoters in XEN cells. NUP153 and 
mAb414 were enriched at both parental Vim and Orai2 promoters, and at the paternal 
Shank2 promoter (n=3).  (D) mAb414 and NUP153 enrichment at the Kcnq1ot1 ICR. Of 
21 sites (arrowheads) examined across the Kcnq1ot1 ICR and enhancer element, significant 
enrichment was observed at regions IC3, IC4, E1 and E2 for mAb414, and regions IC3 and 
IC4 for NUP153.  ICR, imprinting control region; En, enhancer element; TSS, transcription 
start site (n=3). Error bars, s.e.m; *, significance p < 0.05 compared to the siNT or IgG 
controls. 
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Figure 3—7: NUP107/62 and NUP153 interaction with the Kcnq1ot1 ICR, and the 
Osbpl5, Kcnq1, Cd81 promoters in control and Nup-depleted XEN cells. 
 (A) The Kcnq1ot1 domain with regions of analysis (arrowheads); Os1, Os2, Osbpl5 
promoter; Ph1, Ph2, Phlda2 promoter; Sl1, Sl2, Slc22a18 promoter; Ck1, Cdkn1c 
promoter; IC3, IC4, Kcnq1ot1 ICR; E1, E2, putative enhancer element; Kc1, Kc2, Kcnq1 
promoter; Ts1, Ts2, Tssc4 promoter; Cd1, Cd81 promoter; Th1, Th promoter; Ctrl1, Ctrl2: 
control negative sites. (B) Quantitative ChIP analysis using mAb414 antibodies in wild 
type XEN cells at regions across the domain (n=4).  (C) Quantitative ChIP analysis using 
NUP153 antibodies in wild type XEN cells at regions across the domain (n=4).  (D) 
Quantitative allelic analysis for mAb414 in siNT and nucleoporin depleted XEN cells. 
Allelic proportions are represented as percent of the total enrichment levels (n=4).  (E) 
Quantitative allelic analysis for NUP153 in siNT and nucleoporin depleted XEN cells. 
Allelic proportions are represented as percent of the total enrichment levels (n=4). (F) 
NUP107/NUP62 enrichment upon Nup153 depletion was significantly reduced at the 
Kcnq1ot1 ICR. Quantitative ChIP analysis using mAb414 antibodies was performed in 
control and Nup153-depleted XEN cells at sites of NUP153 enrichment (n=3). (G) 
NUP153 enrichment upon Nup107 and Nup62 depletion were significantly reduced at the 
Kcnq1ot1 ICR. Quantitative ChIP analysis using NUP153 antibodies was performed in 
control and Nup107- and Nup62-depleted cells at sites of mAb414 (NUP107/62) 
enrichment (n=3). * indicates significance p < 0.05 compared to the IgG and siNT controls. 
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Figure 3—8: NUP107, NUP62 and NUP153 bound to a Kcnq1ot1 ICR fragment. 
 (A) NUP107, NUP62 and NUP153 supershifted a Kcnq1ot1 ICR fragment but not to a 
control fragment. Electromobility shift assays were performed using biotin-labeled probes 
along with NPC, NUP107, NUP98 and NUP153 antibodies. Supershifts were observed for 
the Kcnq1ot1 ICR biotin-labelled probe and NPC (NUP62/107), NUP107 and NUP153 but 
not NUP98 antibodies and not for a biotin-labelled control region 2 kb upstream of the 
ICR, (n=2-3). (B) NUP107, NUP62 and NUP153 bound to a Kcnq1ot1 ICR fragment but 
not to a control fragment. Biotin-labeled fragments were incubated with control and 
Nup107- and Nup153-depleted XEN cell lysates, and then were immunoprecipitated using 
a streptavidin antibody attached to paramagnetic beads. Following IP washes, samples 
were subjected to Western blot analysis using NUP107, mAb414 (NUP62), NUP98 and 
NUP153 antibodies. NUP62 and NUP153 binding was reduced at the Kcnq1ot1 ICR in 
Nup107-depleted samples, suggesting that NUP107 was required for NUP62 and NUP153 
binding in vitro. However, Nup153 depletion showed continued NUP107 and NUP62 
binding at the Kcnq1ot1 ICR. By comparison, NUP98 did not bind the Kcnq1ot1 ICR.  
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3.5 NUP107, NUP62 and NUP153 regulate paternal allele 
silencing in XEN cells 
Given that aberrant Kcnq1ot1 ncRNA regulation could have domain-wide effects on 
imprinted gene regulation, allelic expression of imprinted protein coding genes in the 
Kcnq1ot1 domain was assessed (Figure 3-9A). Less than 15% expression from the 
normally silent paternal allele was considered repressed, given that controls had 12% 
paternal expression. Nup107 depletion resulted in paternal Osbpl5 (27%), Phlda2 (19%), 
Slc22a18 (47%), Cdkn1c (45%), Kcnq1 (32%) and Tssc4 (27%) reactivation but had no 
effect on paternal Cd81 and Th expression (Figure 3-9B). Nup62 depletion reactivated 
paternal alleles of the same genes as Nup107 depletion, Osbpl5 (23%), Slc22a18 (31%), 
Cdkn1c (32%), Kcnq1 (36%) and Tssc4 (23%), except for Phlda2 (Figure 3-8B). Nup153 
depletion resulted in the same paternal reactivation of the core group of genes, Slc22a18 
(16%), Cdkn1c (39%), Kcnq1 (34%), as well as Cd81 (31%). By comparison, Nup98/96 
depletion had no effect on paternal allelic expression (Figure 3-9B). These data indicate 
that specific nucleoporins play a role in paternal allelic silencing of genes in the Kcnq1ot1 
domain, although not in a domain-wide manner. 
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Figure 3—9: Nup107, Nup62 and Nup153 depletion reactivates a subset of paternal 
alleles at the Kcnq1ot1 domain. 
(A) The Kcnq1ot1 imprinted domain. The paternal Kcnq1ot1 ICR (yellow), containing the 
Kcnq1ot1 ncRNA promoter is unmethylated (white circles). The maternal Kcnq1ot1 ICR 
is methylated (black circles). Arrows, direction of transcription. (B) Allelic expression 
analysis of imprinted genes in control and Nup-depleted XEN cells. Veh, vehicle; siNT, 
non-targeting siRNA; si107, Nup107 siRNA; si62, Nup62 siRNA; si98/96, Nup98/96 
siRNA; si153, Nup153 siRNA (n=3-5). Error bars, s.e.m; *, significance p < 0.05 compared 
to the WT control. 
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3.6 Loss of Kcnq1ot1 domain regulation is not a 
consequence of abrogated nuclear-cytoplasmic 
transport 
One explanation for altered regulation of the Kcnq1ot1 domain upon nucleoporin depletion 
is that aberrant nuclear pore function impaired nuclear-cytoplasmic transport. Previous 
studies have shown that import of cargo containing a classical bipartite nuclear localization 
signal (NLS) was impaired in NUP153-depleted HeLa cells, while transportin cargo was 
not affected (Vollmer et al., 2015). As such, import of exogenous and endogenous NLS-
containing proteins was investigated in control and Nup-depleted XEN cells. For the 
former, XEN cells were transfected with a transcription factor 3 (E47)-red fluorescence 
protein (RFP)-nuclear localization signal (NLS) construct (Mehmood et al., 2011). E47-
RFPNLS XEN cells were in turn transfected with siRNAs. Wildtype XEN cells were treated 
with ivermectin, as a positive control for import inhibition. In contrast to ivermectin-treated 
cells where RFP import was inhibited, control and Nup-depleted XEN cells possessed 
similar nuclear RFP levels (Figure 3-10A). For endogenous nuclear NLS-containing cargo, 
RNAPII, SMC1, SMC3 and INCENP levels were quantified in control and Nup-depleted 
XEN nuclear extracts. No significant differences in protein levels were observed between 
control and Nup-depleted XEN nuclei (Figure 3-10B). Localization of the NLS-containing 
LAMINB1 protein at the internal nuclear membrane was also examined. LAMINB1 
showed normal nuclear rim localization in control and Nup-depleted cells (Figure 3-10C). 
With respect to export, previous studies found aberrant nuclear mRNA export in NUP107-
depleted HeLa cells, with abnormal accumulation of polyA-mRNA in depleted nuclei 
(Boehmer et al., 2003). To assess the levels of mRNA retention upon nucleoporin 
depletion, RNA FISH was performed using a biotin-labeled oligodT probe. No significant 
difference in nuclear polyA mRNA retention levels was observed between control and 
Nup-depleted XEN cells (Figure 3-10D). To address whether export of a single mRNA 
species was compromised and whether passive protein diffusion was disrupted by 
nucleoporin depletion, transport of GFP mRNA and protein was investigated. GFP is a 
small molecule that undergoes bidirectional diffusion though nuclear pores (Seibel et al., 
2007; Wei et al., 2003). XEN cells were transduced with a shRNA targeting the Luciferase 
gene tagged with a GFP reporter protein (shLucGFP) (Golding et al., 2010), and then 
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transfected with siRNAs to examine GFP mRNA nuclear export and GFP protein nuclear 
diffusion. Nup-depleted cells exhibited comparable levels of nuclear and cytoplasmic GFP 
mRNA as well as nuclear GFP protein (Figure 3-10E). To examine endogenous mRNA 
transport, the cytoplasmic localized protein, α-TUBULIN, was quantified in cytoplasmic 
extracts, where the mRNA would have been translated. No significant difference in α-
TUBULIN levels was observed between control and Nup-depleted cells (Figure 3-10B). 
As a final test of NPC transport upon nucleoporin depletion, XEN cell growth rate was 
measured since aberrant import/export may be expected to compromise cellular function 
(Boehmer et al., 2003). No significant change in XEN cell growth rate was observed in 
control and nucleoporin-depleted XEN cells in a direct cell counting assay (Figure 3-11), 
which was similar to what was observed for NUP107 depletion in HeLa cells (Boehmer et 
al., 2003). Overall, these results indicate that nuclear-cytoplasmic transport in XENs cells 
was not affected by nucleoporin depletion. 
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Figure 3—10: Nuclear transport is not altered upon nucleoporin depletion. 
 (A) Endogenous E47-RFPNLS protein transport was not disrupted upon nucleoporin 
depletion, compared to the ivermectin control where nuclear import was blocked. Percent 
nuclear E47-RFPNLS localization was similar in control and nucleoporin-depleted XEN 
cells, compared to ivermectin control. Scale bar, 1 µm; (n=60). (B) Endogenous protein 
transport was not disrupted upon nucleoporin depletion. RNAPII, SMC1, SMC3, and 
INCENP protein levels were the same in control and Nup-depleted XEN nuclear extracts, 
and α-TUBULIN protein levels were unchanged in control and Nup-depleted cytoplasmic 
extracts. Histone 3 (H3) was used as a loading control (n=2-3). (C) LAMINB1 protein 
transport was not altered upon nucleoporin depletion. Control and Nup-depleted XEN cells 
displayed LAMINB1 localization at the nuclear periphery. Scale bar, 1 µM µm; (n=30). 
(D) Nuclear polyA-mRNA retention levels were not changed upon nucleoporin depletion. 
Compared to controls, nucleoporin-depleted cells did not accumulate polyA-mRNA, 
showing similar biotin-lableled oligodT fluorescence levels corrected for background 
levels. Scale bar, 1 µm; error bars, s.e.m; *, significance p < 0.05 compared to the siNT 
control; (n=30-45). (E) GFP mRNA and protein nuclear transport were not disrupted upon 
nucleoporin depletion. Nuclear and cytoplasmic GFP mRNA abundance relative to Gapdh 
expression and nuclear GFP protein levels using H3 as a loading control were similar in 
control and nucleoporin-depleted XEN cells, error bars, s.e.m; *, significance p < 0.05 
compared to the siNT control;  (n=3). 
  
72 
 
 
 
 
 
 
 
 
 
 
 
Figure 3—11: XEN cell growth rate is not altered upon nucleoporin depletion.  
Approximately 25,000 cells were seeded and then transfected 12 hours later with siRNAs. 
Control and Nup-depleted XEN cells were monitored for 60 hours. Direct cell counts were 
performed every 12 hours in triplicate (n=3). No significant changes in cell growth rate 
were observed at different time intervals between samples compared to the WT control. 
  
0
2
4
6
8
10
12
14
0 12 24 36 48 60
Hours
WT
Vehicle
siNT
si107
si62
si98
si153
Ce
ll 
nu
m
be
r (
X 
10
0,
00
0)
/96
73 
 
3.7 Nucleoporin depletion does not alter Kcnq1ot1 ICR 
DNA methylation in XEN cells 
Mechanistically, one explanation for a reduction in paternal Kcnq1ot1 ncRNA levels and 
subsequent paternal allelic reactivation upon Nup107, Nup62 and Nup153 depletion could 
be a gain of DNA methylation at the normal unmethylated paternal ICR. In addition, 
reactivation of maternal Kcnq1ot1 in Nup153-depleted XEN cells could be explained by a 
loss of DNA methylation at the methylated maternal ICR. To assess this, the bisulfite 
mutagenesis and sequencing assay was used to determine parental-specific methylation 
levels at the Kcnq1ot1 ICR in control and Nup-depleted XEN cells. In control cells, the 
maternal Kcnq1ot1 ICR was hypermethylated while the paternal ICR was hypomethylated 
(Figure 3-12). Surprisingly, no gain or loss in DNA methylation was seen at the paternal 
or maternal ICR in Nup-depleted XEN cells (Figure 3-12). Thus, changes in NUP107, 
NUP62 and NUP153 regulation at the Kcnq1ot1 imprinted domain were not through 
alterations in Kcnq1ot1 allelic methylation. 
3.8 Nucleoporin interaction with the Kcnq1ot1 domain 
regulates histone modifications at the domain in XEN 
cells 
Another mechanism that may alter Kcnq1ot1 ncRNA and paternal allelic silencing at the 
Kcnq1ot1 imprinted domain is chromatin state. A gain of repressive modifications at the 
Kcnq1ot1 ICR could account for reduced Kcnq1ot1 ncRNA abundance and a gain of active 
modifications at promoters of imprinted genes could explain paternal allelic reactivation. 
Interaction between mAb414 (NUP107/NUP62), NUP107 and NUP153 and RNA 
polymerase II (RNAPII) provide support for facilitating Kcnq1ot1 gene transcription 
(Figure 3-13A,B). ChIP assays were performed on control and depleted XEN cells using 
antibodies directed against RNAPII and histone 3 lysine 4 trimethylation (H3K4me3) as 
marks for active chromatin, and H3K9me2 and H3K27me3 for repressed chromatin. 
Antibodies were first validated at the XEN cell expressed FoxA2 gene and XEN cell 
repressed MyoD gene (Figure 3-13C) (Golding et al., 2010; Lim et al., 2008).  Active 
FoxA2 and repressive MyoD  modifications  were observed as expected and  were  
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Figure 3—12: DNA methylation is maintained upon nucleoporin depletion. 
Methylation status of the Kcnq1ot1 ICR in control and Nup-depleted XEN cells (n=2). 
Black circles, methylated CpGs; white circles, unmethylated CpGs. Each line represents 
an individual DNA strand. Total methylation percent is represented above each set of DNA 
strands (n=2). WT, wildtype; Veh, vehicle; siNT, non-targeting siRNA; si107, Nup107 
siRNA; si62, Nup62 siRNA; si98/96, Nup98/96 siRNA, si153, Nup153 siRNA 
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not altered upon nucleoporin depletion (Figure 3-13C). Compared to control cells and 
Nup98-depleted cells, there was decreased RNAPII and H3K4me3 enrichment and 
increased H3K9me2 and H3K27me3 enrichment on the paternal Kcnq1ot1 ICR in Nup107-
, Nup62- and Nup153-depleted cells (Figure 3-14), which would account for reduced 
paternal Kcnq1ot1 ncRNA levels. In addition, we observed increased H3K4me3 and 
RNAPII enrichment along with decreased repressive histone modifications on the maternal 
Kcnq1ot1 ICR upon Nup153 depletion, which could account for reactivation of the 
maternal transcript (Figure 3-14). Compared to control cells, we also observed significantly 
increased enrichment of RNAPII and H3K4me3 at the paternal Slc22a18, Cdkn1c and 
Kcnq1 alleles upon Nup107, Nup62 and Nup153 depletion, H3K4me3 at the paternal 
Osbpl5 promoter upon Nup107 and Nup62 depletion, and RNAPII and H3K4me3 at the 
paternal Cd81 promoter upon Nup153 depletion, thereby accounting for their paternal 
reactivation (Figure 3-14). Conversely, there were significantly reduced levels of 
H3K9me2 and/or H3K27me3 at the paternal Slc22a18, Cdkn1c and Kcnq1 promoters upon 
Nup107, Nup62 and Nup153 depletion, and at the paternal Cd81 promoter upon Nup153 
depletion. Additional decreases in H3K9me2 and/or H3K27me3 at the paternal Tssc4 and 
Th promoters upon Nup107 and Nup153 depletion, although this did not correlate with any 
change in paternal allele expression. Consistent with maintenance of paternal allelic 
repression, no significant changes in histone modifications were observed upon Nup98 
depletion, except for at the Th promoter, where a significant decrease in paternal 
H3K27me3 enrichment was seen (Figure 3-14). These results demonstrate that NUP107, 
NUP62 and NUP153 act to regulate histone modifications at the Kcnq1ot1 ICR and specific 
imprinted gene promoters. 
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Figure 3—13: Nucleoporin-RNAPII interactions, and validation of active and 
repressive chromatin modifications at the FoxA2 and MyoD genes. 
(A) RNAPII interacted with nucleoporins in XEN cells. mAb414 IP was performed 
followed by Western blot analysis using an RNAPII antibody, which showed positive 
interactions (n=2).  (B) Nucleoporins interacted with RNAPII in XEN cells. RNAPII IP 
was performed followed by Western analysis using mAb414 (NUP62), NUP107 and 
NUP153 antibodies, which demonstrated positive interactions (n=2-3).  (C) Active and 
repressive chromatin ChIP validation at the FoxA2 and MyoD genes in XEN cells. ChIP 
analysis using RNAPII, H3K4me3, H3K9me2 and H3K27me3 antibodies at FoxA2 and 
MyoD promoters. The expressed FoxA2 promoter (Golding et al., 2010) harbored active 
chromatin modification, RNAPII and H3K4me3, and low levels of repressive 
modifications, H3K9me2 and H3K27me3. Conversely, the repressed MyoD promoter (Lim 
et. al. 2008) was enriched for repressive modifications but lacked active chromatin 
modification. No significant change in enrichment levels was observed upon nucleoporin 
depletion compared to the siNT control (n=3).  
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Figure 3—14: Nucleoporin depletion disrupts histone modifications at the Kcnq1ot1 
ICR and imprinted gene promoters. 
(A) RNAPII and H3K4me3 ChIP at the maternal and paternal Kcnq1ot1 ICR and imprinted 
gene promoters in control and Nup-depleted XEN cells (n=3).  Allelic proportions are 
represented as a percent of the total enrichment level. (B) H3K9me2 and H3K27me3 ChIP 
at the maternal and paternal Kcnq1ot1 ICR and imprinted gene promoters in control and 
Nup-depleted XEN cells (n=3).  Allelic proportions are represented as a percent of the total 
enrichment level. WT, wildtype; Veh, vehicle; siNT, non-targeting siRNA; si107, Nup107 
siRNA; si62, Nup62 siRNA; si98/96, Nup98/96 siRNA, si153, Nup153 siRNA; error bars, 
s.e.m; *, significance p < 0.05 compared to the siNT control. 
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3.9 Nucleoporins regulate cohesin complex interactions at 
the Kcnq1ot1 ICR in XEN cells 
Another mechanism that may alter Kcnq1ot1 imprinted domain regulation is 
CTCF/cohesin complex binding. Previous studies have identified two CTCF-binding site 
within the Kcnq1ot1 ICR that were bound by CTCF and the cohesin complex in mouse 
embryonic fibroblasts (Fitzpatrick et al., 2007; Hark et al., 2000). While one study found 
that CTCF-binding at the Kcnq1ot1 ICR was paternal-specific, the other study observed 
that CTCF and cohesin bound with equal affinity to the maternal and paternal Kcnq1ot1 
ICRs (Fitzpatrick et al., 2007). Regardless of allelic binding, CTCF and the cohesin 
complex may have regulatory roles at the Kcnq1ot1 imprinted domain. To determine 
whether CTCF and the cohesin complex interact with the nucleoporins, co-IP assays were 
performed. We observed positive interaction of mAb414, NUP107 and NUP153 with 
CTCF and the cohesin complex proteins, SMC1 and SMC3 (Figure 3-15A,B). To 
determine whether CTCF, SMC1 and SMC3 localized at the mAb414-positive enrichment 
sites, ChIP was performed using CTCF, SMC1 and SMC3 antibodies in XEN cells at the 
Kcnq1ot1 ICR, and for CTCF in embryonic stem cells at the maternal H19 ICR, as a 
positive control (Fitzpatrick et al., 2007; Hark et al., 2000; Prickett et al., 2013). As 
expected, strong CTCF enrichment was observed on the H19 maternal allele, whereas no 
CTCF enrichment was observed at the Kcnq1ot1 ICR and putative enhancer region (Figure 
3-15C), indicating that CTCF does not bind to these sites in XEN cells. By comparison, 
SMC1 and SMC3 binding was significantly enriched at IC3 and IC4, but not at other tested 
sites, with preferential cohesin binding at the paternal IC3 and IC4 sites (Figure 3-15A,B). 
Upon Nup107- and Nup62 co-depletion and Nup153 depletion, SMC1 and SMC3 
enrichment was significantly decreased at the paternal IC3 and IC4 sites (Figure 3-16A,B). 
These results indicate that NUP107, NUP62 and/or NUP153 interact with the cohesin 
complex at the paternal Kcnq1ot1 ICR.  
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Figure 3—15: Nucleoporin-CTCF and cohesin complex protein interactions in XEN 
cells, and CTCF enrichment at the H19 ICR CTCF positives in ES cells but not at 
Kcnq1ot1 ICR CTCF positives sites in XEN cells. 
(A) CTCF and cohesin complex proteins were interacting partners of nucleoporins in XEN 
cells.  mAb414 IP was performed followed by Western blot analysis using CTCF, SMC1, 
SMC3, NUP107 and NUP153 antibodies, which showed positive interactions (n=2-3).  (B) 
CTCF, SMC1, and SMC3 IP was performed followed by Western analysis using mAb414, 
NUP107 and NUP153 antibodies, which demonstrated positive interactions (n=2-3).  (C) 
CTCF was enriched at the H19 ICR in ES cells but not at the Kcnq1ot1 ICR in XEN cells. 
As a control for the CTCF antibody, one positive site at the H19 ICR and one negative site 
within H19 exon 5 (Ex5) (arrowheads) were were examined for CTCF enrichment in ES 
cells. Significant CTCF enrichment was observed at the maternal H19 ICR as a positive 
control but not at the negative control exon 5 (Ex5) site (n=3). (D) Seven sites (arrowheads) 
with mAb414 and/or NUP153 enrichment at the Kcnq1ot1 ICR and enhancer element were 
examined for CTCF enrichment). No significant CTCF enrichment was observed at the 
Kcnq1ot1 ICR and enhancer element in XEN cells (n=3).Error bars, s.e.m; *, significance 
p < 0.05 compared to IgG control. 
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Figure 3—16: SMC1 and SMC3 enrichment at the paternal Kcnq1ot1 ICR was 
reduced upon nucleoporin depletion. 
 (A) Quantitative ChIP analysis and allelic analysis for (A) SMC1 and (B) SMC3 at 
positive mAb414 and NUP153 enrichment sites in control and Nup107/Nup62-double-
depleted and Nup153-depleted XEN cells (n=3). Allelic proportions are represented as a 
percent of the total enrichment level. Error bars, s.e.m; *, significance p < 0.05 compared 
to the siNT control. 
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Chapter 4  
4  Results  
The Kcnq1ot1 domain exhibits both tissue-specific and developmental stage-specific 
regulation. Between embryonic and extraembryonic lineages, there is a clear difference 
between imprinted regulation of the protein-coding genes. At the Kcnq1ot1 domain, genes 
are classified by their expression during mid-gestation development as inner/ubiquitously 
imprinted genes (i.e. imprinted expression in embryonic and placental tissue), Phlda2, 
Slc22a18, Cdkn1c, Kcnq1 and Kcnq1ot1, and outer placental-specific imprinted genes, 
Osbpl5, Nap1l4, Tssc4, Cd81, Ascl2 and Th (Lewis et al. 2004; Umlauf et al. 2004; Golding 
et al. 2011; Mohammad et al. 2012). Currently, it is unclear when embryonic and 
extraembryonic lineages acquired differential imprinted domain regulation and how this 
differential regulation is regulated. For my second aim, I hypothesized that nucleoporins 
will have different regulatory roles or may act on different sets of genes within the 
Kcnq1ot1 imprinted domain in ES, TS and XEN cells. To test this hypothesis, I evaluated 
the role of NUP107, NUP62, NUP98 and NUP153 in the regulation of the Kcnq1ot1 
imprinted domain in ES and TS stem cells.   
4.1 Nup107, Nup62 and Nup153 depletion alters Kcnq1ot1 
ncRNA expression in ES and TS cells 
Wild type C57BL6 x Mus musculus castaneus ES and TS cells were transfected with two 
sets of siRNA’s targeting Nup107, Nup62, Nup98/96 and Nup153. Compared to controls, 
RNA and protein levels were depleted to less than 30% of control levels in ES and TS cells 
(Figure 4-1). To determine the role on nucleoporins in regulating Kcnq1ot1 ncRNA 
expression, total and allele-specific expression levels for the Kcnq1ot1 ncRNA were 
assessed in control and Nup-depleted ES and TS cells. Nup107 and Nup62 depletion 
produced a significant decrease in Kcnq1ot1 ncRNA levels in both ES (0.34 and 0.42) and 
TS (0.40 and 0.49) cells with expression restricted to the paternal allele (Figure 4-2). By 
comparison, no significant difference was observed between control and Nup98- or 
Nup153-depleted ES and TS cells. Nup98-depleted ES and TS cells maintained paternal 
86 
 
Kcnq1ot1 expression, while Nup153 depletion in ES and TS cells resulted in reactivation 
of the maternal Kcnq1ot1 allele to 22.3% and 25.9% (Figure 4-2B). This suggests that 
NUP153 depletion resulted in reduced paternal Kcnq1ot1 ncRNA expression levels by at 
least 20-25% of control cells. These results are similar to our previous finding in XEN cells 
where a 24% decrease in Kcnq1ot1 expression levels was observed upon Nup153 depletion.  
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Figure 4—1: Nucleoporin depletion levels in ES and TS cells.  
Nucleoporin RNA (left) and protein (right) depletion levels in ES and TS cells. 
Quantitative real-time PCR analysis for Nup107, Nup62, Nup98/96 and Nup153 relative to 
Gapdh expression 48 hours after transfection (left). Transfections were performed using 
the two different sets of siRNAs (A and B; n=3). The Nup98 gene is a bicistronic gene that 
encodes for two separate nucleoporins, NUP98 and NUP96, from one mRNA. Since the 
siRNAs target the mRNA that will produce both proteins, the siRNAs have been designated 
si98/96. The NUP98 antibody specifically recognized NUP98; no commercial antibody 
was available for NUP96. Western blot analysis for nucleoporins was performed 48 hours 
after transfection. Histone 3 (H3) was used as loading control. Transfections were 
performed using the two different sets of siRNAs (n=6). Error bars indicate s.e.m. *, 
significance p < 0.05 compared to the WT control; Veh, vehicle; siNT, non-targeting 
siRNA; si107, Nup107 siRNA; si62, Nup62 siRNA; si98/96, Nup98/96 siRNA; si153, 
Nup153 siRNA.  
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Figure 4—2: Nup107, Nup62 and Nup153 depletion disrupts Kcnq1ot1 ncRNA 
expression, domain volume and nuclear periphery localization.  
(A) Real-time Kcnq1ot1 ncRNA expression levels normalized to Gapdh. (B) Allelic 
Kcnq1ot1 ncRNA expression in control and Nup-depleted ES and TS cells (n=4). (C) 
Representative nuclear images displaying Kcnq1ot1 ncRNA (green), LAMINB1 (red) and 
DAPI staining (blue) for G1-synchronized control and Nup-depleted ES and TS cells (n=3). 
(D) Percent of cells with paternal or maternal Kcnq1ot1 ncRNA signals. (E) Percent of 
cells with Kcnq1ot1 ncRNA signal volume; low, 0-0.7 µm3; medium, 0.7-1.4 µm3; high, 
1.4-2.1 µm3; very high, >2.1 µm3. B6, maternal (red); CAST; paternal (blue); error bars, 
s.e.m; *, significance p < 0.05 compared to the vehicle control; WT, wildtype; Veh, 
vehicle; siNT, non-targeting siRNA; si107, Nup107 siRNA; si62, Nup62 siRNA; si98/96, 
Nup98/96 siRNA, si153, Nup153 siRNA, scale bar, 1 µm; n=4; cell count number=100. 
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4.2 NUP107, NUP62 and NUP153 regulate Kcnq1ot1 
ncRNA volume in ES and TS cells 
To determine whether reduced paternal Kcnq1ot1 ncRNA abundance and reactivation of 
the maternal Kcnq1ot1 transcript altered Kcnq1ot1 volume, 3D RNA FISH was performed 
for Kcnq1ot1 along with immunofluorescence for nuclear periphery marker LAMINB1. 
Consistent with the expression analysis (Figure 4-2B), Kcnq1ot1 ncRNA localization was 
restricted to the paternal Kcnq1ot1 domain in control and Nup107- and Nup62-depleted ES 
and TS cells, while the Kcnq1ot1 ncRNA localized to both parental domains in Nup153-
depleted ES and TS cells (Figure 4-2C,D). In control ES and TS cells, 68-71% and 69-78% 
of cells possessed a Kcnq1ot1 ncRNA volume in the medium volume range (0.7-1.4 µm3) 
with the remaining cells in the low (<0.7 µm3, 3-7% and 10-12%) and the high (1.4-2.1 
µm3, 12-21 and 7-15%) to very high (1.4-2.1 µm3, 8-10 and 3-6%) volume ranges, 
respectively (Figure 4-2E). In ES and TS cells, a significant increase was observed in cells 
with low Kcnq1ot1 ncRNA volumes upon Nup107 depletion (66% and 71%, respectively) 
and Nup62 depletion (73% and 62%, respectively). For Nup153 depletion, a significant 
increase was also found for ES and TS cells in the low volume range for the paternal 
Kcnq1ot1 ncRNA (32% and 41%, respectively). While the maternal Kcnq1ot1 allele was 
not expressed in control and Nup107-, Nup62- and Nup98/96-depleted ES and TS, 92% 
and 83% of Nup153 depletion ES and TS cells, respectively, displayed maternal Kcnq1ot1 
ncRNA volumes in the lower range.  Nup98/96 depletion did not alter the Kcnq1ot1 ncRNA 
volume in ES or TS cells in contrast to XEN cells where I saw a significant increase in 
Kcnq1ot1 ncRNA volume. To determine whether decreased transcript abundance and 
volume was correlated with altered stability of the Kcnq1ot1 ncRNA, control and Nup-
depleted ES and TS cells were treated with actinomycin D to block transcription and 
transcript half-life was measured. Kcnq1ot1 ncRNA was not altered between control and 
Nup-depleted ES and TS cells (Figure 4-3), suggesting the reduced Kcnq1ot1 ncRNA 
volumes were a result of altered Kcnq1ot1 ncRNA expression. 
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Figure 4—3: Kcnq1ot1 ncRNA stability is not altered upon nucleoporin depletion in 
ES and TS cells. 
Control and Nup-depleted ES and TS cells were treated with actinomycin D for 1 hour, 
after which cells were collected up to 12 hours after release from treatment. Kcnq1ot1 
expression levels were normalized to 0 hours. No significant changes in Kcnq1ot1 ncRNA 
levels were seen at different time intervals between samples and the WT control, indicating 
that there was no difference in Kcnq1ot1 ncRNA half-life in control and Nup-depleted XEN 
cells (n=3). Error bars indicate s.e.m. *, significance p < 0.05; Veh, vehicle; siNT, non-
targeting siRNA; si107, Nup107 siRNA; si62, Nup62 siRNA; si98/96, Nup98/96 siRNA; 
si153, Nup153 siRNA.  
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4.3 NUP107, NUP62 and NUP153 regulate Kcnq1ot1 
domain positioning in ES and TS cells 
I previously showed that the Kcnq1ot1 ncRNA-coated domain was localized at the nuclear 
periphery in XEN cells. Upon Nup107, Nup62, and Nup153 depletion, nuclear periphery 
positioning was shifted to the sub-nuclear periphery and nuclear interior. Comparatively, 
while the volume increased, nuclear periphery positioning was mostly maintained in 
Nup98/96-depleted XEN cells. To test whether the nuclear periphery position of the 
Kcnq1ot1-coated domain was similarly altered upon Nup-depletion in ES and TS cells, 
DNA/RNA FISH was performed in G1-synchronized control and Nup-depleted ES and TS 
cells. In control and Nup-depleted cells, there was complete overlap of Kcnq1ot1 ncRNA 
with the Kcnq1ot1 domain (Figure 4-4A,B). Positioning within the nucleus was 
categorized as nuclear periphery, sub-nuclear periphery and nuclear interior. The larger 
domain with Kcnq1ot1 ncRNA signal (where visible) and the smaller domain without 
Kcnq1ot1 ncRNA signal were designated as the paternal and maternal domains, 
respectively. In the controls, the Kcnq1ot1 domain was positioned at the nuclear periphery 
in 86-92% and 83-88%, the sub-nuclear periphery in 5-9% and 4-15%, and the nuclear 
interior in 3-5% and 2-3% of ES and TS cells, respectively. Nup107 depletion resulted in 
decreased positioning of the Kcnq1ot1 domain at the nuclear periphery in 64% and 52%, 
and increased positioning at the sub-nuclear periphery in 27% and 34%, and nuclear 
interior in 9% and 14% of ES and TS cells, respectively. A similar shift to the sub-nuclear 
periphery and nuclear interior was observed in Nup62- and Nup153-depleted ES and TS 
cells. No significant change in positioning was observed upon Nup98/96 depletion. To 
determine whether there was any correlation between Kcnq1ot1 ncRNA volume and 
Kcnq1ot1 domain positioning, ncRNA volume and distance from nuclear periphery was 
correlated for both ES and TS cells. In G1-synchronized control ES and TS cells, the 
Kcnq1ot1 ncRNA primarily localized at the nuclear periphery with medium Kcnq1ot1 
ncRNA volumes (Figure 4-5). Upon Nup107, Nup62 and Nup153 depletion, ES and TS 
cells with lower Kcnq1ot1 ncRNA volumes were situated away from the nuclear periphery. 
Nup98/96-depleted cells displayed similar volumes and positioning as control cells. These 
results suggest that NUP107, NUP62, and NUP153 play a role in directing the Kcnq1ot1 
domain to the nuclear periphery in ES and TS cells, similar to XEN cells. 
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Figure 4—4: Nup107, Nup62 and Nup153 depletion disrupts Kcnq1ot1 domain 
nuclear periphery localization. 
Nucleoporin depletion disrupted Kcnq1ot1 DNA nuclear periphery localization in ES (A) 
and TS (B) cells. Representative DNA/RNA FISH images are shown for control Nup-
depleted ES and TS cells. Graph represents quantification of the distance of the DNA FISH 
signal from the nuclear periphery. Upon nucleoporin depletion, Kcnq1ot1 DNA 
localization shifts away from the nuclear periphery. Nuclear periphery, 0-0.5 µm; sub-
nuclear periphery, 0.6-1.5 µm; nuclear interior, 1.6-4 µm; scale bar, 1 µM; m, maternal 
domain; p, paternal domain; *, significance p < 0.05 compared to the vehicle control; n=4; 
cell count number=100. 
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Figure 4—5: Kcnq1ot1 ncRNA volume to distance correlation in control and 
nucleoporin-depleted ES and TS cells 
Kcnq1ot1 ncRNA volume correlated with distance from nuclear periphery in ES (A) and 
TS (B) cells. Kcnq1ot1 ncRNA volume and distance from nuclear periphery were plotted 
on X- and Y-axes, respectively, for G1-synchronized control and Nup-depleted XEN cells. 
Upon Nup107, Nup62 and Nup153 depletion, cells with low Kcnq1ot1 ncRNA volume 
shifted to sub-nuclear peripheral and nuclear interior positions. Nuclear Periphery; SP, 
Sub-nuclear Periphery; NI, Nuclear Interior; Veh, vehicle; siNT, non-targeting siRNA; 
si107, Nup107 siRNA; si62, Nup62 siRNA; si98/96, Nup98/96 siRNA; si153, Nup153 
siRNA; P, paternal; M, maternal; n=100.  
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4.4 Nucleoporins physically interact with the Kcnq1ot1 
domain in ES and TS cells 
In the previous chapter on XEN cells, I observed that NUP107/NUP62 (mAb414) were 
enriched at the Kcnq1ot1 ICR, the enhancer element and the Osbpl5 promoter on the 
paternal allele, whereas NUP153 was enriched at the Kcnq1ot1 ICR, and the Kcnq1 and 
Cd81 promoters. To investigate nucleoporin proteins interactions at the Kcnq1ot1 
imprinted domain in ES and TS cells (Figure 4-6), quantitative ChIP was performed using 
the mAb414 antibody that primarily interacts with NUP62, NUP107 and NUP160, as 
shown before in mouse XEN cells, as well as the NUP153 antibody; ChIP-grade NUP107 
and NUP62 antibodies were not available.  In ES cells, significant NUP107/NUP62 
(mAb414) occupancy was observed at the Cdkn1c promoter (Ck1), the Kcnq1ot1 ICR (IC3, 
100 bp upstream; IC4, 1.7kb downstream of Kcnq1ot1 TSS), and the Kcnq1ot1 enhancer 
element (E1 and E2) (Fig 4-6). By comparison, NUP153 binds to the Kcnq1ot1 ICR (IC3, 
IC4), and the Cd81 (Cd1) and Th (Th1) promoters. In TS cells, NUP107/NUP62 (mAb414) 
enrichment was restricted to the Kcnq1ot1 ICR (IC3, IC4) and enhancer element (E1, E2), 
while NUP153 was enriched only at the Kcnq1ot1 ICR (IC3, IC4) (Fig 4-6B). To examine 
whether nucleoporin-chromatin interactions were lost upon Nup depletion, ChIP was 
performed using the mAb414 and NUP153 antibodies at the positive enrichment and 
negative (Ctrl2) sites in siNT control and Nup107/Nup62 double-depleted, and Nup153-
depleted ES and TS cells. Compared to control ES cells, NUP107/NUP62 enrichment was 
significantly decreased at the Cdkn1c promoter, Kcnq1ot1 ICR and enhancer element sites 
upon Nup107/Nup62 double-depletion (Figure 4-7). NUP153 depletion in ES cells 
similarly produced a significant reduction in NUP153 enrichment at the enhancer element 
and Cd81 and Th sites (Fig 4-7B). In TS cells, NUP107/NUP62 enrichment was 
significantly reduced at the Kcnq1ot1 ICR and enhancer element sites in Nup107/Nup62 
double-depleted cells compared to the control (Fig 4-7C), while there was a significant 
reduction of NUP153 enrichment at the Kcnq1ot1 ICR sites upon Nup153 depletion (Fig 
4-7D). For all interactions, reduced NUP107/NUP62 and NUP153 enrichment was found 
at the paternal allele in Nup-depleted cells compared to the control cells, except for 
NUP153 enrichment which was decreased at both the maternal and paternal Cd81 sites in 
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Nup153-depleted ES cells. This result contrasts with those obtained in XEN cells, where 
NUP153 enrichment was found at both the maternal and paternal Kcnq1ot1 ICR sites. In 
XEN cells, I found that nucleoporin interactions at the paternal Kcnq1ot1 ICR were 
cooperatively mediated through NUP107, NUP62 and NUP153. I next investigated their 
interdependency in ES and TS cells. In both ES and TS cells, upon Nup153 depletion, 
NUP107/NUP62 enrichment at the Kcnq1ot1 ICR and enhancer element sites was 
significantly reduced compared to controls (Fig 4-7E,F). Likewise, Nup107/Nup62 double-
depletion in ES and TS cells resulted in a significant decrease in NUP153 enrichment at 
the Kcnq1ot1 ICR sites (Fig 4-7E,F). These results indicate that NUP107, NUP62 and 
NUP153 interactions at the paternal Kcnq1ot1 ICR were cooperatively mediated in XEN, 
ES and TS cells.  
 
I next investigated whether nucleoporins can directly interact with Kcnq1ot1 ICR using 
biotin-labelled DNA fragments and nuclear lysates from control and Nup-depleted XEN 
cells.  Reverse ChIP was performed to isolate proteins bound to a biotin-labelled Kcnq1ot1 
ICR fragment containing the IC3 enrichment site, as well as a negative control fragment 
located 2-kb upstream of the Kcnq1ot1 ICR. This was followed by Western blot analysis 
using mAb414, NUP107 and NUP153 antibodies. NUP107 bound directly to the Kcnq1ot1 
ICR fragment but not the control fragment (Figure 4-8). Nup107-depleted lysates abrogated 
NUP107 binding to levels observed for the control fragment. Furthermore, NUP62 
(detected by the mAb414 antibody) and NUP153 binding was also reduced, indicating that 
NUP62 and NUP153 binding at the Kcnq1ot1 ICR required NUP107 binding. NUP153 
also bound directly to the IC3-containing Kcnq1ot1 ICR fragment but not the control 
fragment. Upon Nup153 depletion, binding was lost. However, NUP107 and NUP62 
binding to the Kcnq1ot1 ICR fragment was not altered, perhaps indicating that there was 
sequential binding of NUP107/NUP62 and NUP153 in this in vitro system.  
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Figure 4—6: NUP107/62 and NUP153 interact with the Kcnq1ot1 ICR, enhancer 
site, Cdkn1c and the Osbpl5, Cd81 and Th promoters in wildtype cells. 
(A) The Kcnq1ot1 domain with regions of analysis (arrowheads); Os1, Os2, Osbpl5 
promoter; Ph1, Ph2, Phlda2 promoter; Sl1, Sl2, Slc22a18 promoter; Ck1, Cdkn1c 
promoter; IC3, IC4, Kcnq1ot1 ICR; E1, E2, putative enhancer element; Kc1, Kc2, Kcnq1 
promoter; Ts1, Ts2, Tssc4 promoter; Cd1, Cd81 promoter; Th1, Th promoter; Ctrl1, Ctrl2: 
control negative sites. Partial blue genes represent maternal bias expression in ES cells. (B) 
Quantitative ChIP analysis using mAb414 and NUP153 antibodies in wild type ES cells at 
regions across the domain (n=4).  (C) Quantitative ChIP analysis using mAb414 and 
NUP153 antibodies in wild type TS at regions across the domain (n=4).  Error bars, s.e.m; 
*, significance p < 0.05 compared to the IgG control. 
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Figure 4—7: NUP107/62 and NUP153 interaction with the Kcnq1ot1 domain in 
control and Nup-depleted ES and TS cells  
(A, B) Total enrichment and quantitative allelic analysis at positive and negative sites for 
mAb414 in siNT and Nup107/Nup62- and Nup153-depleted ES (A) and TS (B) cells. 
Allelic proportions are represented as percent of the total enrichment levels (n=4). (C, D) 
Total enrichment and quantitative allelic analysis for NUP153 in siNT and Nup107/Nup62- 
and Nup153-depleted ES (C) and TS (D) cells. Allelic proportions are represented as 
percent of the total enrichment levels (n=4). (E, F) NUP107/NUP62 enrichment was 
significantly reduced at the Kcnq1ot1 ICR and enhancer site upon Nup153 depletion in ES 
and TS cells. Quantitative ChIP analysis using mAb414 antibodies was performed in 
control and Nup153-depleted ES and TS cells at sites of mAb414 enrichment (n=3).  
NUP153 enrichment was significantly reduced at the Kcnq1ot1 ICR upon Nup107/Nup62 
depletion in ES and TS cells. Quantitative ChIP analysis using NUP153 antibodies was 
performed in control and Nup107/62-depleted cells at sites of NUP153 enrichment in ES 
and TS cells (n=3). Error bars, s.e.m; *, significance p < 0.05 compared to the siNT control. 
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Figure 4—8: NUP107, NUP62 and NUP153 bound to the Kcnq1ot1 ICR fragment. 
(A) NUP107, NUP62 and NUP153 bound to a Kcnq1ot1 ICR fragment but not to a control 
fragment. Biotin-labeled fragments were incubated with control and Nup107- and Nup153-
depleted ES cell lysates, and then were immunoprecipitated using a streptavidin antibody 
attached to paramagnetic beads. Following IP washes, samples were subjected to Western 
blot analysis using NUP107, NUP62 (mAb414) and NUP153 antibodies. NUP62 and 
NUP153 binding was reduced at the Kcnq1ot1 ICR in Nup107-depleted samples, 
suggesting that NUP107 was required for NUP62 and NUP153 binding in vitro. However, 
Nup153 depletion showed continued NUP107 and NUP62 binding at the Kcnq1ot1 ICR in 
this in vitro system. 
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4.5 Nucleoporin proteins regulate paternal allele silencing 
in ES and TS cells 
Given the changes in NUP107, NUP62 and NUP153 interactions at the Kcnq1ot1 domain, 
I next determined whether these alterations exerted any effect on domain-wide imprinted 
gene expression. The effects of Nup-depletion on expression of imprinted genes were 
assessed in ES and TS cells. Expression less than 15% from the normally silent paternal 
allele was considered repressed. Cd81 was considered to have maternal-biased expression, 
with less than 25% paternal expression. In ES cells, Osbp15, Slc22a18, Ascl2 and Th were 
biallelically expressed, with no change in paternal expression upon Nup depletion (Figure 
4-9). Similar to XEN cells, Nup depletion had no effect on paternal Phlda2 and Tssc4 
repression. Compared to controls, paternal Cdkn1c was reactivated upon Nup107, Nup62 
and Nup153 depletion but not Nup98/96 depletion, similar to XEN cells. Unlike XEN cells, 
depletion of Nup107, Nup62 and Nup153 in ES cells produced no change in paternal Kcnq1 
expression. Instead, Nup98/96 depletion in ES cells resulted in reactivation of the paternal 
Kcnq1 allele. Finally, similar to XEN cells, Nup153 depletion reactivated Cd81 paternal 
expression in ES cells.  
 
In TS cells, Osbp15, Tssc4, Cd81, Ascl2 and Th were biallelically expressed, with no 
change in paternal expression upon Nup depletion (Figure 4-9). Similar to XEN cells, Nup 
depletion had no effect on paternal Phlda2 repression. Compared to controls, Nup107, 
Nup62 and Nup153 depletion in TS cells resulted in reactivation of the paternal Cdkn1c, 
Kcnq1 and Slc22a18, while no change in paternal repression was observed in Nup98-
depleted TS cells, similar to XEN cells. These results indicate that nucleoporins play a role 
in paternal allelic silencing of multiple imprinted genes in the Kcnq1ot1 domain, although 
not in a domain-wide manner. They also highlight the differences in paternal allelic 
repression in ES, TS and XEN cells.  
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Figure 4—9: Nucleoporin depletion reactivates a subset of paternal alleles at the 
Kcnq1ot1 domain in ES and TS cells.  
The Kcnq1ot1 imprinted domain in ES (A) and TS (B) cells. The paternal Kcnq1ot1 ICR 
(yellow), containing the Kcnq1ot1 ncRNA promoter is unmethylated (white circles). The 
maternal Kcnq1ot1 ICR is methylated (black circles). Arrows, direction of transcription. 
(C-D) Allelic expression analysis of imprinted genes in control and Nup-depleted ES (C) 
and TS (D) cells. Veh, vehicle; siNT, non-targeting siRNA; si107, Nup107 siRNA; si62, 
Nup62 siRNA; si98/96, Nup98/96 siRNA; si153, Nup153 siRNA (n=3-5). Error bars, 
s.e.m; *, significance p < 0.05 compared to the WT control. 
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4.6 Loss of Kcnq1ot1 domain regulation is not a 
consequence of abrogated nuclear-cytoplasmic 
transport 
There are several explanations for altered regulation of the Kcnq1ot1 domain upon Nup 
depletion. This includes a change in nuclear transport, since one of the primary functions 
of the nucleoporin proteins is nuclear-cytoplasmic import and export. Previously, we 
showed that Nup107, Nup62, Nup98/96 and Nup153 depletion did not alter nuclear-
cytoplasmic import or export mechanisms in XEN cells. Given the differences in stem cell 
profiles, we wanted to determine the status of nuclear-cytoplasmic transport in ES and TS 
cells upon nucleoporin depletion. First, I determined whether transport of NLS-containing 
proteins was altered in Nup-depleted ES and TS cells. No significant difference was 
observed in endogenous proteins with the classic NLS in nuclear import upon Nup 
depletion in both ES and TS nuclear extracts (Fig 4-10). Similarly, no significant difference 
was observed in the cytoplasmic retention of E47NLS-Red fluorescent protein (RFP) tag in 
transfected ES and TS cells. This contrasts with cells treated with the nuclear import 
inhibitor, Ivermectin, which displayed cytoplasmic retention of the E47NLS-RFP (Fig 4-
10B). To determine whether Nup depletion altered nuclear export, RNA FISH was 
performed using a polyA-mRNA probe to determine nuclear mRNA retention levels in 
control and Nup-depleted samples. Nuclear polyA-mRNA retention levels remain 
unchanged upon Nup depletion (Fig 4-10C). As a final test of NPC transport function upon 
nucleoporin depletion, ES and TS cell growth rate was measured. No significant alteration 
in ES and TS cell growth rate was observed in control and nucleoporin-depleted ES and 
TS cells in a direct cell counting assay (Fig 4-11). Therefore, these results suggest that 
nuclear import and export mechanisms in ES and TS cells were not disrupted upon 
nucleoporin depletion. 
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Figure 4—10: Nuclear transport is not altered upon nucleoporin depletion.  
(A) Endogenous protein transport was not disrupted upon nucleoporin depletion. CTCF, 
SMC1, SMC3, INCENP protein levels in nuclear extracts, and α-TUBULIN protein levels 
in cytoplasmic extracts were unchanged in control and Nup-depleted ES cells. In TS cells, 
CTCF, RNAPII, INCENP protein levels in nuclear extracts, and α-TUBULIN protein 
levels in cytoplasmic extracts were the same in control and Nup-depleted samples. Histone 
3 (H3) was used as a loading control (n=2-3). (B) Endogenous E47-RFPNLS protein 
transport was not disrupted upon nucleoporin depletion, compared to the ivermectin control 
where nuclear import was blocked in ES and TS cells. Percent nuclear E47-RFPNLS 
localization was similar in control and nucleoporin-depleted ES and TS cells, compared to 
ivermectin control. Scale bar, 1 µm; error bars, s.e.m; *, significance p < 0.05 compared to 
the siNT control; (n=50). (C) Nuclear polyA-mRNA retention levels were not changed 
upon nucleoporin depletion. Compared to controls, nucleoporin-depleted ES and TS cells 
did not accumulate polyA-mRNA, showing similar biotin-lableled oligodT fluorescence 
levels corrected for background levels. Scale bar, 1 µm; error bars, s.e.m; *, significance p 
< 0.05 compared to the siNT control; (n=40).  
 
 
  
112 
 
 
 
Figure 4—11: Nucleoporin depletion does not alter ES and TS cell growth rate.  
ES and TS cells were plated at 20% confluency and transfected with control or nucleoporin 
specific siRNAs. Cells were counted at intervals of every 12 hours. No significant change 
in ES or TS cell growth rate was observed at different time intervals between samples 
compared to the WT control.  
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4.7 Nucleoporin depletion does not alter Kcnq1ot1 ICR 
DNA methylation  
A second explanation for altered regulation of the Kcnq1ot1 domain upon Nup depletion 
was a change in DNA methylation at the Kcnq1ot1 ICR. More specifically, reduced 
paternal Kcnq1ot1 expression in Nup107, Nup62 and Nup153-depleted cells could be 
correlated with a gain in DNA methylation at the paternal Kcnq1ot1 ICR whereas 
reactivation of the normally-silent maternal Kcnq1ot1 in Nup153-depleted cells could be 
due to a loss of DNA methylation at the ICR. Similar to XEN cells, the DNA methylation 
status of the Kcnq1ot1 ICR was unaltered in Nup-depleted cells ES or TS cells (Fig 4-12).   
  
114 
 
 
  
siNTWT Veh
siNup62 siNup98/96 siNup107 siNup153
WT siNT Veh
siNup62 siNup98/96 siNup107 siNup153
A
B
86% 95% 95%
3%3%4%
95% 95% 95% 95%
95% 95% 95%
95% 95% 95% 95%
4% 4% 4% 4%
4% 4% 4%
4% 4% 4% 4%
ES
 c
el
ls
TS
 c
el
ls
115 
 
Figure 4—12: DNA methylation is maintained upon nucleoporin depletion. 
Methylation status of the Kcnq1ot1 ICR in control and Nup-depleted ES and TS cells (n=2). 
Black circles, methylated CpGs; white circles, unmethylated CpGs. Each line represents 
an individual DNA strand. Total methylation percent is represented above each set of DNA 
strands (n=2). WT, wildtype; Veh, vehicle; siNT, non-targeting siRNA; si107, Nup107 
siRNA; si62, Nup62 siRNA; si98/96, Nup98/96 siRNA, si153, Nup153 siRNA 
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4.8 Nucleoporins regulate histone modifications at the 
Kcnq1ot1 domain in ES and TS cells 
Another explanation for altered regulation of the Kcnq1ot1 domain upon Nup depletion is 
a change in histone modifications. Increased repressive modifications at the Kcnq1ot1 ICR 
could explain the reduced levels of Kcnq1ot1 ncRNA while an increase in active 
modifications at imprinted gene promoters could account for paternal allelic reactivation. 
ChIP assays were performed on control and Nup-depleted ES and TS cells using RNA 
polymerase II (RNAPII) and histone 3 lysine 4 trimethylation (H3K4me3) antibodies as 
marks for active transcription, and H3K9me2 and H3K27me3 antibodies as marks for 
repressed chromatin. As a control, active and repressive modifications were first validated 
at the ES cell expressed Oct4, and the TS cell expressed Cdx2 gene promoters (Lim et. al. 
2008). As expected, in ES cells, the Oct4 promoter, and in TS cells, the Cdx2 promoter 
showed H3K4me3 and RNAPII occupancy and lacked enrichment for H3K9me2 and 
H3K27me3 in control and Nup-depleted cells (Fig 4-13). Conversely, in ES cells, the Cdx2 
promoter, and in TS cells, the Oct4 promoter exhibited enrichment of repressive but not 
active modifications in control and Nup-depleted-cells. Next, quantitative-allelic ChIP was 
performed at the Kcnq1ot1 ICR and promoters of imprinted genes. Compared to control 
ES and TS cells, Nup107-, Nup62-, and Nup153-depleted cells had significantly decreased 
RNAPII and H3K4me3 enrichment at the paternal Kcnq1ot1 ICR (Fig 4-14). Note that 
allelic enrichment was represented relative to total enrichment levels. This may account 
for the decreased Kcnq1ot1 ncRNA expression levels upon Nup107, Nup62, and Nup153 
depletion. In addition, for Nup153 depletion, a significant decrease in H3K9me2 and 
H3K27me3 enrichment was observed at the maternal Kcnq1ot1 ICR in both ES and TS 
cells, offering an explanation for reactivation of the maternal Kcnq1ot1 ncRNA. I also 
performed ChIP analysis at the promoters of imprinted genes. In ES cells, we observed a 
significant increase in RNAPII and H3K4me3 levels and a concurrent decrease in 
H3K9me2 and H3K27me3 at the paternal Cdkn1c promoter upon Nup107, Nup62 and 
Nup153 depletions compared to controls. Moreover, compared to ES cell controls, 
significantly increased RNAPII and H3K4me3 enrichment and significantly decreased 
H3K9me2 and H3K27me3 enrichment was observed at the paternal Kcnq1 promoter upon 
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Nup98 depletion, and at the paternal Cd81 promoter in Nup153 depleted ES cells.  
Compared to TS cell controls, there was a significant increase in RNAPII and H3K4me3 
levels along with a significant decrease in H3K9me2 and H3K27me3 levels at the paternal 
Slc22a18, Cdkn1c and Kcnq1 promoters upon Nup107, Nup62 and Nup153 depletion. 
Notably, no changes in RNAPII or histone modification enrichment was observed for the 
Tssc4 and/or Phlda2 promoters, which retained paternal allelic repression in Nup-depletion 
ES and TS cells (Fig 4-15). Similar to XEN cells, these results indicate that NUP107, 
NUP62 and NUP153 act to regulate histone modifications at the Kcnq1ot1 ICR and specific 
imprinted gene promoters. 
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Figure 4—13: Validation of active and repressive chromatin modifications at the 
Oct4 and Cdx2 genes in ES and TS cells. 
ChIP analysis using RNAPII, H3K4me3, H3K9me2 and H3K27me3 antibodies at Oct4 
and Cdx2 promoters. In ES cells, the expressed Oct4 promoter harbored active chromatin 
modification, RNAPII and H3K4me3, and low levels of repressive modifications, 
H3K9me2 and H3K27me3. Conversely, the repressed Cdx2 promoter was enriched for 
repressive modifications but lacked active chromatin modification in ES cells. In TS cells, 
the expressed Cdx2 promoter harbored active chromatin modification, RNAPII and 
H3K4me3, and low levels of repressive modifications, H3K9me2 and H3K27me3. 
Conversely, the repressed Oct4 promoter was enriched for repressive modifications but 
lacked active chromatin modification in ES cells. No significant change in enrichment 
levels was observed upon nucleoporin depletion (n=3). Error bars, s.e.m; *, significance p 
< 0.05 compared to the siNT control. 
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Figure 4—14: Nucleoporin depletion disrupts histone modifications at the Kcnq1ot1 
ICR and at reactivated imprinted gene promoters in ES and TS cells. 
(A) RNAPII, H3K4me3, H3K9me2 and H3K27me3 ChIP at the maternal and paternal 
Kcnq1ot1 ICR and imprinted gene promoters in control and Nup-depleted ES cells (n=3).  
Allelic proportions are represented as a percent of the total enrichment level. (B) RNAPII, 
H3K4me3, H3K9me2 and H3K27me3 ChIP at the maternal and paternal Kcnq1ot1 ICR 
and imprinted gene promoters in control and Nup-depleted TS cells (n=3). Allelic 
proportions are represented as a percent of the total enrichment level. WT, wildtype; Veh, 
vehicle; siNT, non-targeting siRNA; si107, Nup107 siRNA; si62, Nup62 siRNA; si98/96, 
Nup98/96 siRNA, si153, Nup153 siRNA. error bars, s.e.m; *, significance p < 0.05 
compared to the siNT control. 
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Figure 4—15: Nucleoporin depletion did not alter histone modifications at 
imprinted gene promoters, where paternal allelic-silencing was maintained in ES 
and TS cells. 
RNAPII, H3K4me3, H3K9me2 and H3K27me3 ChIP at the maternal and paternal 
Kcnq1ot1 ICR and imprinted gene promoters in control and Nup-depleted ES (Phlda2 and 
Tssc4) and TS (Phlda2) cells (n=3).  Allelic proportions are represented as a percent of the 
total enrichment level. WT, wildtype; Veh, vehicle; siNT, non-targeting siRNA; si107, 
Nup107 siRNA; si62, Nup62 siRNA; si98/96, Nup98/96 siRNA, si153, Nup153 siRNA. 
error bars, s.e.m; *, significance p < 0.05 compared to the siNT control. 
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4.9 Nucleoporins regulate CTCF/cohesin complex at the 
Kcnq1ot1 ICR in ES cells but not in TS cells 
Another explanation for altered regulation of the Kcnq1ot1 domain upon Nup depletion is 
a change in CTCF and/or cohesin proteins interactions at the domain. Previously, I found 
that the cohesin proteins, SMC1 and SMC3, but not CTCF were enriched on the paternal 
Kcnq1ot1 ICR (IC3 and IC4) in XEN cells. Here, I determined the role of CTCF and the 
SMC1/SMC3 proteins in nucleoporin-mediated imprinted domain regulation. As a control, 
ChIP was performed using CTCF, SMC1 and SMC3 antibodies in ES and TS cells, and 
was assessed for binding at the H19 ICR and Peg3 differentially methylated region (DMR) 
as positive controls, and H19 exon 5 and Peg3 exon 2 as negative controls (Prickett et al., 
2013). CTCF, SMC1 and SMC3 enrichment was observed at the H19 ICR preferentially 
on the maternal allele in ES cells but not at the H19 ICR in TS cells (Fig 4-16). CTCF, 
SMC1 and SMC3 were enriched at Peg3 DMR preferentially on the paternal allele in ES 
and TS cells, albeit at lower levels in the latter. Next, I assessed CTCF interactions at the 
Kcnq1ot1 ICR and enhancer element sites (Fig 4-17A). In ES cells, I observed CTCF 
enrichment at the two previously identified CTCF-binding sites (IC3, IC4) (Fitzpatrick et 
al., 2007; Hark et al., 2000) within the Kcnq1ot1 ICR (Fig 4-15B) . SMC1 and SMC3 
enrichment was also observed at the Kcnq1ot1 IC3 and IC4 sites (Fig 4-16B). Surprisingly, 
no enrichment of CTCF, SMC1 or SMC3 was observed at the Kcnq1ot1 ICR sites in TS 
cells (Fig 4-16). Thus, the effects of Nup depletion were only determined for ES cells. 
Compared to controls, a significant decrease in CTCF, SMC1 and/or SMC3 enrichment 
was found at the Kcnq1ot1 ICR sites (IC3, IC4) upon Nup107, Nup62 and Nup153 
depletion.  In control ES cells, this enrichment was biased toward the paternal allele.  In 
Nup107-, Nup62- and Nup153-depleted ES cells, CTCF, SMC1 and SMC3 enrichment was 
significantly reduced at the paternal the Kcnq1ot1 ICR sites (Figure 4-17). These results 
indicate that NUP107, NUP62 and/or NUP153 play a role in CTCF and cohesin complex 
interaction on the paternal Kcnq1ot1 ICR in ES cells. By comparison, only the cohesin 
complex bound to the paternal Kcnq1ot1 ICR in XEN cells, while neither CTCF nor the 
cohesin complex bound the paternal Kcnq1ot1 ICR in TS cells. 
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Figure 4—16: CTCF, SMC1 and SMC3 localization at the H19 and Peg3 domains in ES 
and TS cells 
CTCF, SMC1 and SMC3 ChIP at the H19 ICR and Peg3 DMR in control and Nup-depleted 
ES and TS cells (n=3). Allelic analysis indicated a maternal bias enrichment for CTCF, 
SMC1 and SMC3 at H19 ICR and a paternal bias enrichment for CTCF, SMC1 and SMC3 
at the Peg3 DMR (n=3).  
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Figure 4—17: CTCF, SMC1 and SMC3 enrichment at the Kcnq1ot1 ICR and 
enhancer site in ES and TS cells  
(A) Map of the primer test sites for Kcnq1ot1 ICR and enhancer region. (B). In ES cells 
CTCF, SMC1 and SMC3 enrichment was seen at the IC3 and IC4 regions. (C). No CTCF, 
SMC1 and SMC3 enrichment was seen at sites along the ICR and enhancer in TS cells.  
Error bars, s.e.m; *, significance p < 0.05 compared to IgG control. 
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Figure 4—18: CTCF, SMC1 and SMC3 enrichment at the paternal Kcnq1ot1 ICR is 
reduced upon nucleoporin depletion in ES cells. 
(A) Quantitative ChIP analysis and allelic analysis for (A) CTCF, (B) SMC1 and (C) SMC3 
at positive mAb414 and NUP153 enrichment sites in control and Nup107, Nup62 and 
Nup153-depleted ES cells (n=3). Allelic proportions are represented as a percent of the 
total enrichment level. Error bars, s.e.m; *, significance p < 0.05 treatment compared to the 
siNT control. 
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Chapter 5  
5 Discussion 
The mechanisms by which the Kcnq1ot1 imprinted domain is regulated is poorly 
understood. It is not clear what regulates the paternal expression of the Kcnq1ot1 ncRNA. 
Furthermore, mechanisms regulating paternal allelic silencing of the neighbouring-protein 
coding genes are poorly understood. Currently, it is not known whether nucleoporins play 
a role in regulating Kcnq1ot1 domain imprinting. Furthermore, the mechanisms 
responsible for regulating the Kcnq1ot1 domain in three lineages of the preimplantation 
embryo are poorly understood. The purpose of this study was to determine the role of 
nucleoporin proteins in Kcnq1ot1 imprinted domain regulation in XEN cells and to 
determine whether this mechanism was conserved in ES and TS cells. Overall, I have 
identified a novel mechanism of imprinted domain regulation, namely nucleoporin-
mediated imprinted domain regulation at the Kcnq1ot1 domain. I determined that 
nucleoporin proteins regulate Kcnq1ot1 ncRNA expression, Kcnq1ot1 domain localization 
to the nuclear rim and silencing of protein-coding genes on the paternal allele in a 
nucleoporin-specific manner in ES, TS and XEN cells. Very few epigenetic factors have 
been identified that regulate genomic imprinting. Perturbations in either imprint 
establishment or maintenance at the KCNQ1OT1 domain result imprinting defects that 
have severe consequences for growth and development including Beckwith-Wiedemann 
Syndrome. Therefore, my results establish an important role for nucleoporins NUP107, 
NUP62 and NUP153 in mediating imprinted domain regulation in all three cell lineages 
that represent the early embryo.  
 
My data indicate that NUP107, NUP62 and NUP153 regulated paternal Kcnq1ot1 ncRNA 
expression, paternal Kcnq1ot1 domain positioning at the nuclear periphery, and paternal 
allelic silencing of specific imprinted genes in XEN stem cells (Figure 5-1). NUP107, 
NUP62 and NUP153 were bound at the Kcnq1ot1 ICR on the paternal allele in XEN cells. 
In addition, I found that NUP107, NUP62 and NUP153 maintained active chromatin at the 
Kcnq1ot1 ICR and a repressed conformation at the paternal alleles of imprinted genes that 
130 
 
had been reactivated upon Nup depletion. The cohesin complex, but not CTCF, assembled 
at the same sites within the paternal Kcnq1ot1 ICR as NUP107, NUP62 and NUP153, and 
binding was reduced upon Nup depletion. Similar to XEN cells, NUP107, NUP62 and 
NUP153 regulated paternal Kcnq1ot1 ncRNA expression and paternal Kcnq1ot1 domain 
positioning at the nuclear periphery in ES and TS cells (Figures 5-2, 5-3). While NUP107, 
NUP62 and NUP153 regulated paternal allelic silencing of specific imprinted genes in all 
three stem cell lines, the genes regulated differed. NUP107, NUP62 and NUP153 were 
bound at the Kcnq1ot1 ICR on the paternal allele in ES, TS and XEN cells, as well as at 
paternal alleles of imprinted genes that had been reactivated upon Nup depletion. 
Compared to XEN cells, where the cohesin complex, but not CTCF, assembled at the 
paternal Kcnq1ot1 ICR with NUP107, NUP62 and NUP153, both CTCF and the cohesin 
complex bound to the paternal Kcnq1ot1 ICR in a NUP107, NUP62 and NUP153-
dependent manner in ES cells, while in TS cells neither CTCF nor cohesin assembled at 
the paternal Kcnq1ot1 ICR. These results indicate that NUP107, NUP62 and NUP153 
regulate imprinting at the Kcnq1ot1 domain by a nucleoporin-mediated mechanism in ES, 
TS and XEN cells, although in a cell lineage-specific manner. My work opens up a new 
dimension to understand imprinted domain regulation and role of nucleoporins. 
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Figure 5—1: Summary of nucleoporin-mediated regulation of the Kcnq1ot1 
imprinted domain in XEN cells 
 
NUP107, NUP62 and NUP153 regulated paternal Kcnq1ot1 ncRNA expression, paternal 
Kcnq1ot1 domain positioning at the nuclear rim, and paternal allelic silencing of specific 
imprinted genes in XEN stem cells. NUP107, NUP62 and NUP153 were bound at the 
Kcnq1ot1 ICR on the paternal allele in XEN cells. In addition, we found that NUP107, 
NUP62 and NUP153 maintained active chromatin at the Kcnq1ot1 ICR. The cohesion 
complex, but not CTCF, assembled at the same sites within the paternal Kcnq1ot1 ICR as 
NUP107, NUP62 and NUP153. Upon Nup107 and Nup62 depletion, Kcnq1ot1 ncRNA 
expression was significantly reduced, which was correlated with a change in histone 
modifications at the Kcnq1ot1 ICR, and the paternal Kcnq1ot1 domain was shifted away 
from the nuclear rim. NUP107 and NUP62 had reduced binding at the the Kcnq1ot1 ICR 
and the enhancer element. NUP153 and cohesin binding were also reduced at the Kcnq1ot1 
ICR. Furthermore, the paternal allele of the core group of genes, Slc22a18, Cdkn1c and 
Kcnq1 was reactivated, with a corresponding change in histone modifications. The silent 
paternal Osbpl5 and Phlda2 were also reactivated by little to no change in histone 
modifications. Similar alterations to Nup107- and Nup62-depleted XEN cells were 
observed upon Nup153 depletion. Here, the normally-silent, maternal Kcnq1ot1 ncRNA 
was reactivated. NUP153 had reduced binding at the Kcnq1ot1 ICR, the Kcnq1ot promoter 
and Cd81 promoter. NUP107, NUP62 and cohesin binding were also reduced at the 
Kcnq1ot1 ICR. Furthermore, the paternal allele of the core group of genes, Slc22a18, 
Cdkn1c and Kcnq1, as well as Cd81 were reactivated, with a corresponding change in 
histone modifications. For all Nup-depletion, DNA methylation state was maintained. 
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Figure 5—2: Summary of nucleoporin-mediated regulation of the Kcnq1ot1 
imprinted domain in ES cells 
 
NUP107, NUP62 and NUP153 regulated paternal Kcnq1ot1 ncRNA expression, paternal 
Kcnq1ot1 domain positioning at the nuclear rim, and paternal allelic silencing of specific 
imprinted genes in XEN stem cells. NUP107, NUP62 and NUP153 were bound at the 
Kcnq1ot1 ICR on the paternal allele in XEN cells. In addition, we found that NUP107, 
NUP62 and NUP153 maintained active chromatin at the Kcnq1ot1 ICR. The CTCF and 
the cohesion complex, assembled at the same sites within the paternal Kcnq1ot1 ICR as 
NUP107, NUP62 and NUP153. Upon Nup107 and Nup62 depletion, Kcnq1ot1 ncRNA 
expression was significantly reduced, which was correlated with a change in histone 
modifications at the Kcnq1ot1 ICR, and the paternal Kcnq1ot1 domain was shifted away 
from the nuclear rim. NUP107 and NUP62 had reduced binding at the  Kcnq1ot1 ICR and 
the enhancer element. NUP153 and CTCF/cohesin binding were also reduced at the 
Kcnq1ot1 ICR. Furthermore, the paternal allele of Cdkn1c was reactivated, with a 
corresponding change in histone modifications. Similar alterations to Nup107- and Nup62-
depleted XEN cells were observed upon Nup153 depletion. Here, the normally-silent, 
maternal Kcnq1ot1 ncRNA was reactivated. NUP153 had reduced binding at the Kcnq1ot1 
ICR, the Kcnq1ot promoter and Cd81 promoter. NUP107, NUP62 and cohesin binding 
were also reduced at the Kcnq1ot1 ICR. Furthermore, Cdkn1c and Cd81 were reactivated, 
with a corresponding change in histone modifications. For all Nup-depletion, DNA 
methylation state was maintained. 
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Figure 5—3: Summary of nucleoporin-mediated regulation of the Kcnq1ot1 
imprinted domain in TS cells 
NUP107, NUP62 and NUP153 regulated paternal Kcnq1ot1 ncRNA expression, paternal 
Kcnq1ot1 domain positioning at the nuclear rim, and paternal allelic silencing of specific 
imprinted genes in TS cells. NUP107, NUP62 and NUP153 were bound at the Kcnq1ot1 
ICR on the paternal allele in XEN cells. In addition, we found that NUP107, NUP62 and 
NUP153 maintained active chromatin at the Kcnq1ot1 ICR. Neither CTCF or cohesin 
complex binding was observed in TS cells. Upon Nup107 and Nup62 depletion, Kcnq1ot1 
ncRNA expression was significantly reduced, which was correlated with a change in 
histone modifications at the Kcnq1ot1 ICR, and the paternal Kcnq1ot1 domain was shifted 
away from the nuclear rim. NUP107 and NUP62 had reduced binding at the the Kcnq1ot1 
ICR and the enhancer element. NUP153 binding was also reduced at the Kcnq1ot1 ICR. 
Furthermore, the paternal allele of the core group of genes, Slc22a18, Cdkn1c and Kcnq1 
was reactivated, with a corresponding change in histone modifications. Similar alterations 
to Nup107- and Nup62-depleted XEN cells were observed upon Nup153 depletion. Here, 
the normally-silent, maternal Kcnq1ot1 ncRNA was reactivated. NUP153 had reduced 
binding at the Kcnq1ot1 ICR, the Kcnq1ot promoter and Cd81 promoter. NUP107 and 
NUP62 binding were also reduced at the Kcnq1ot1 ICR. Furthermore, the paternal allele 
of the core group of genes, Slc22a18, Cdkn1c and Kcnq1 were reactivated, with a 
corresponding change in histone modifications. For all Nup-depletion, DNA methylation 
state was maintained. 
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5.1 Nucleoporin 107, 62 and 153 regulate Kcnq1ot1 
domain both on- and off-pore 
Previous studies have shown a coordinate role of NUP107 and NUP62 at spindles and 
kinetochores (Glavy et al., 2007), where they may play a role in chromatin reorganization 
upon nuclear membrane reformation (Kalverda et al., 2010). NUP107 and NUP62 may 
have a similar role at the Kcnq1ot1 domain by coordinating chromatin organization at the 
domain during each cell cycle. Alternatively, the regulatory role of NUP107 and NUP62 
may be independent of mitosis and nuclear membrane reformation. Recently, NUP153 was 
reported to play a role in PRC1-mediated silencing of developmentally regulated genes in 
embryonic stem cells, along with tethering at the nuclear periphery (Jacinto et al., 2015). 
This is consistent with the reactivation of the normally silent maternal Kcnq1ot1 allele 
upon Nup153 depletion in XEN, ES and TS cells. The coordinate binding of NUP107 and 
NUP62 with NUP153 likely mediates its regulatory role in active Kcnq1ot1 ncRNA 
transcription, pointing to a dual role for NUP153. A recent study showed that human 
NUP98 binds to chromatin, and upon depletion decreased H3K4me2 and RNAPII at target 
promoters, suggesting a role in gene activation (Light et al., 2010; Light et al., 2013). Here, 
I observed increased Kcnq1ot1 ncRNA transcription upon Nup98/96 depletion in XEN 
cells (not in ES or TS cells), without a change in histone modification, leading us to theorize 
that NUP98 may mediate its function via enhancer interactions, although this requires 
further investigations.  
 
Interactions between NUP107, NUP62 and NUP153 have previously been documented in 
HeLa cells. NUP107 depletion decreased NUP153 levels but not NUP62 levels, although 
both NUP153 and NUP62 localization at the nuclear periphery was reduced (Boehmer et 
al., 2003; Walther et al., 2003). NUP62 depletion produced a decrease in NUP153 levels 
(Hashizume et al., 2013), while NUP153 depletion led to patchy NUP107 localization at 
the nuclear periphery (Vollmer et al., 2015). A recent study investigating various 
nucleoporin interactions in U2OS 2-6-3 cells found that only four nucleoporins (NUP153, 
NUP50, NUP107, NUP133) of the eleven tested had the capacity to recruit multiple 
nucleoporins (Schwartz et al., 2015). NUP153 recruited multiple nucleoporins including 
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NUP62 and NUP107-160 complex members. This NUP153-initiated structure repositioned 
an integrated chromatin marker from the nuclear interior to the nuclear periphery in 76% 
of cells. NUP107 similarly recruited multiple nucleoporins and positioned the chromatin 
marker to the nuclear periphery, although with lower frequency (25% of cells). By 
comparison, NUP98 possessed very limited nucleoporin recruitment and lacked the 
capacity to target chromatin to the nuclear periphery. In keeping with this data, I found that 
Nup107, Nup62 and Nup153 depletion diminished Kcnq1ot1 domain positioning at the 
nuclear periphery.   
 
To determine the interdependency between NUP107/62 and NUP153 binding, I assessed 
NUP107/62 enrichment upon Nup153 depletion and NUP153 enrichment upon Nup107 
and Nup62 depletion. In all three cell lineages, depletion of either Nup153, or Nup107 and 
Nup62 resulted in reduced enrichment of NUP107/62 and NUP153 at the Kcnq1ot1 ICR. 
This suggests that NUP107/62 and NUP153 act cooperatively at the Kcnq1ot1 ICR, thereby 
tethering the Kcnq1ot1 domain to nuclear periphery. Upon Nup107, Nup62 or Nup153 
depletion, this nuclear peripheral positioning of the Kcnq1ot1 domain is lost. Having said 
this, other sites within the domain maintain their enrichment upon Nup153 depletion, or 
Nup107 and Nup62 depletion. For example, in XEN cells, NUP107 and NUP62 remained 
bound at the Osbpl5 promoter and the enhancer site upon Nup153 depletion. Similarly, 
NUP153 remained bound to Cd81 promoters in ES cells and XEN cells upon Nup107 and 
Nup62 depletion. However, even when these nucleoporin interactions are maintained, the 
Kcnq1ot1 domain shifted away from the nuclear periphery. The most likely explanation 
for this is that NUP107/62 and NUP153 bound to and tethered the Kcnq1ot1 ICR to the 
nuclear periphery through the nuclear pore complex, while NUP107/62 and NUP153 
binding at other regions of the domain were through an off-pore function. Recent studies 
have identified multiple nucleoporins, including NUP62, NUP153, NUP98 and NUP50, 
that are present in the nucleoplasm as mobile soluble fractions and regulate genes away 
from the nuclear periphery by binding to their promoters (Buchwalter et al., 2014; Griffis 
et al., 2004; Liang et al., 2013; Jacinto 2015).  
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5.2 Requirement for the Kcnq1ot1 noncoding RNA 
The Kcnq1ot1 noncoding RNA plays a role in paternal allelic silencing of both ubiquitous 
and placenta-specific imprinted genes in midgestation embryos. It was anticipated that 
upon reduced Kcnq1ot1 ncRNA expression, there would be similar domain-wide paternal 
allelic silencing, similar to what was observed for targeted deletion of the Kcnq1ot1 ICR 
and truncation of the Kcnq1ot1 ncRNA (Shin et al., 2008). While I observed a decrease in 
Kcnq1ot1 ncRNA abundance upon nucleoporin depletion in all three stem cell lines, 
paternal allelic silencing was not domain-wide; a different set of genes had paternal allelic 
reactivation across the three lineages. Furthermore, the Phlda2, Kcnq1, Tssc4, Cd81, Ascl2 
and Th genes maintained paternal allelic silencing in at least one stem cell line upon 
nucleoporin depletion. This questions whether the Kcnq1ot1 ncRNA is required for 
paternal allelic silencing during early development stages, and if so, how the Kcnq1ot1 
ncRNA mediates differential silencing within the Kcnq1ot1 domain. One possibility is that 
the Kcnq1ot1 ncRNA act in a gene-specific manner to silence the paternal Slc22a18, 
Cdkn1c and Kcnq1 alleles in XEN and TS cells, and Cdkn1c in ES cells. Genes more distal 
from the Kcnq1ot1 ICR would be regulated by a Kcnq1ot1 ncRNA-independent 
mechanism. Having said this, data from our lab showed that depletion of the Kcnq1ot1 
ncRNA failed to reactivate paternal alleles of imprinted genes in the Kcnq1ot1 domain in 
XEN, ES and TS cells. Instead, it was concluded that it was likely the act of Kcnq1ot1 
ncRNA transcription rather than the ncRNA itself which functioned to silence paternal 
alleles (Golding et al., 2011). Consistent with a transcription role, Nup107, Nup62 and 
Nup153 depletion reduced active chromatin modifications at the paternal Kcnq1ot1 ICR in 
ES and TS cells, and reduced active and increased repressive chromatin modifications at 
the paternal Kcnq1ot1 ICR in XEN cells. However, a Kcnq1ot1 transcription interference 
mechanism would not account for gene-specific paternal allelic reactivation, since only the 
paternal Kcnq1 and/or Cd81 alleles (not Tssc4 and Th) in XEN cells, the Cd81 allele (not 
Kcnq1 and Tssc4) in ES cells, and the Kcnq1 allele (not Ascl2) in TS cells were reactivated. 
Overall, these results suggest that it is an open chromatin conformation at the Kcnq1ot1 
ICR, an active Kcnq1ot1 promoter and/or some yet to be determined function of the 
Kcnq1ot1 ncRNA (RNA adaptor; RNA scaffold) that mediates paternal allelic silencing. 
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Whichever the case, the mechanism by which gene-specific paternal allelic silencing is 
enacted requires further investigation. 
 
Previous studies have shown that the Kcnq1ot1 domain is compartmentalized to the 
nuclear periphery or perinucleolar regions (Mohammad et al., 2008; Redrup et al., 2009). 
Here, Nup107, Nup62 and Nup153 depletion caused a loss of nuclear periphery 
localization for the paternal Kcnq1ot1 domain in G1-synchronized ES, TS and XEN cells. 
Despite this repositioning within the nucleus, the Kcnq1ot1 ncRNA remained associated 
with the Kcnq1ot1 domain in Nup107-, Nup62- and Nup153-depleted ES, TS and XEN 
cells, albeit with lower Kcnq1ot1 volumes. This indicates that the Kcnq1ot1 ncRNA per 
se does not regulate paternal Kcnq1ot1 domain positioning at the nuclear periphery.  
 
5.3 Nucleoporin 107, 62 and 153 in higher order chromatin 
structure 
One intriguing finding from my study was that imprinted genes within the Kcnq1ot1 
domain were not co-ordinately regulated. To gain a better understanding of domain 
regulation, data from Pope et. al. was mined to map topological associated domains within 
the Kcnq1ot1 domain. We found that the Kcnq1ot1 domain mapped into three TADs in 
embryonic stem cells (Macdonald et al., 2015; Pope et al., 2014). The first TAD contains 
the Osbpl5 gene plus 3 non-imprinted genes, the second TAD extends from Phlda2 to the 
Kcnq1 promoter, while the third TAD covers Tssc4 to Th (Figure 5-4). Given the stable 
nature of TADs across cell types (Dixon et al., 2012; Korostowski et al., 2011), I propose 
a model for nucleoporin regulation at the Kcnq1ot1 domain. Within TAD 1, 
NUP107/NUP62 bound at the paternal Osbpl5 promoter region in XEN cells. This 
interaction may isolate Osbpl5 from non-imprinted genes in this TAD. Upon Nup107 and 
Nup62 depletion, paternal Osbpl5 may be relocated into the non-imprinted gene loop. 
Consistent with this, in ES and TS cells, the paternal Osbpl5 promoter region was not 
bound by NUP107/NUP62 and the paternal Osbpl5 allele was expressed, suggesting that 
it resides within the non-imprinted gene loop.  
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Within TAD 3, the paternal Tssc4, Cd81 and Th alleles were repressed in XEN cells, the 
paternal Tssc4 and Cd81 alleles were silenced in ES cells, while the paternal Ascl2 allele 
was repressed in TS cells. In XEN and ES cells, NUP153 bound to the paternal Cd81 
promoter region. Upon Nup153 depletion, only paternal Cd81 silencing was disrupted in 
XEN and ES cells, suggesting that Cd81 may be incorporated into the neighbouring non-
imprinted gene loop.  
 
Within central TAD 2, NUP107/NUP62 and NUP153 were bound to the paternal Kcnq1ot1 
ICR, and NUP107/NUP62 was bound to the paternal 8 kb-downstream enhancer element 
in all three cell lineages. In XEN cells, the cohesin complex also assembled at the paternal 
Kcnq1ot1 ICR. By comparison, in ES cells, both CTCF and the cohesin complex interacted 
with the paternal Kcnq1ot1 ICR. In ES cells, a second interaction with NUP107/NUP62 
was observed at the paternal Cdkn1c promoter region, while in XEN cells, 
NUP107/NUP62 also interacted with the Kcnq1 promoter region. Thus, in XEN and ES 
cells, NUP107/NUP62 and NUP153 together with cohesin and/or CTCF may facilitate 
promoter-enhancer interactions and/or boundary function, enabling an active loop for 
Kcnq1ot1 ncRNA transcription, while excluding Cdkn1c and Kcnq1. Consistent with this, 
a previous study reported that a paternal 200 kb-intrachromosomal loop existed between 
the Kcnq1 promoter and enhancers in fibroblast cells, that maintained paternal Kcnq1 
silencing (Korostowski et al., 2011; Zhang et al., 2014). Upon Nup107, Nup62 and Nup153 
depletion, Kcnq1ot1 ICR-putative enhancer interaction or boundary function may be 
disrupted, repressing Kcnq1ot1 ncRNA transcription and allowing enhancer interactions or 
euchromatin spreading into other genes in this TAD. For XEN cells, this would include the 
paternal Slc22a18, Cdkn1c and Kcnq1 alleles while for ES cells, spreading would be 
limited to the paternal Cdkn1c allele. For TS cells, neither CTCF nor the cohesin complex 
assembled at the paternal Kcnq1ot1 ICR. This may suggest that other proteins may mediate 
chromatin interactions/chromatin looping within TAD2. Upon Nup107, Nup62 and 
Nup153 depletion, paternal Kcnq1ot1 ncRNA transcription would be repressed and the 
paternal Slc22a18, Cdkn1c and Kcnq1 reactivated.   
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Figure 5—4: Proposed model of topological organization of the paternal Kcnq1ot1 
imprinted domain orchestrated by nucleoporins in XEN, ES and TS cells. 
The paternal Kcnq1ot1 imprinted domain separated in three distinct topologically 
associated domains (TADs, dashed lines) in XEN, ES and TS cells.  Within TAD2, the 
Kcnq1ot1 ICR (orange) and putative enhancer (green) interact with NUP107, NUP62 and 
NUP153, and the cohesin complex in XEN cells and CTCF/cohesin complex in ES cells, 
facilitating promoter-enhancer interactions or chromatin boundary function. This results in 
active chromatin loop formation, which allows for Kcnq1ot1 noncoding RNA 
transcription. The remaining genes in TAD2 reside outside the active chromatin loop and 
are repressed. In TS cells, this interaction is independent of CTCF and cohesin complex. 
In XEN cells, within TAD1, an additional site of NUP107 and NUP62 binding is present 
at the paternal Osbpl5 promoter. This may generate a chromatin boundary between 
repressive and active chromatin, placing Osbpl5 in repressive chromatin while other 
expressed, non-imprinted genes reside in an active chromatin loop. In ES and TS cells, 
Osbpl5 is expressed and possibly located within the active chromatin loop. TAD3 consists 
of paternally silenced genes as well non-imprinted genes that are expressed. NUP153 binds 
at the Cd81 promoter in XEN and ES cells, placing Cd81 in repressive chromatin and the 
neighboring expressed, non-imprinted genes in an active chromatin loop. In TS cells, the 
paternal Cd81 is expressed. For non-imprinted genes in the domain, please note their 
imprint and expression status has not been determined in XEN cells. Also note that I have 
drawn the domain linearly and that there may be subTAD interactions generating different 
conformation or loops than what is displayed here. Model is not to scale. 
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5.4 Future Directions 
Based on the results of the present study, I propose a model where NUP107/NUP62 and 
NUP153 facilitates chromatin-chromatin interactions and chromatin loop formation on the 
paternal allele in partnership with the cohesin complex and/or CTCF, or other epigenetic 
factors in XEN, ES and TS cell respectively. Future studies need to be directed toward 
understanding the role of nucleoporins in chromatin structure at the Kcnq1ot1 domain in 
ES, TS and XEN cells. These studies would include performing Hi-C, which is a chromatin 
conformation capture method followed by high-throughput sequencing. Hi-C analysis in 
control stem cells will determine chromatin-chromatin interactions and potential chromatin 
boundaries, as well as allow the comparison of TAD profiles between the three stem cell 
lineages. Furthermore, Hi-C analysis in nucleoporin-depleted stem cells will determine 
which chromatin interactions and chromatin boundaries are dependent on nucleoporins. 
Once TAD boundaries important to imprinted domain regulation are identified, 
CRISPR/Cas9 technology can be used to generate mutations that alter these boundaries to 
determine their functional role during development.  
 
Future studies are also needed to understanding the role of nucleoporins in the nuclear 
architecture at the Kcnq1ot1 domain. Lamin-associated domains (LADs) are regions of 
chromatin that are bound to Lamin B1 (Guelen et al. 2008). Unlike TADs that remain 
largely stable across cell and tissue types, LADs can be constitutive or dynamic. LaminB1-
ChIP sequencing could be performed to identify LADs in XEN, ES and TS cells. Mapping 
of LADs within the Kcnq1ot1 domain may account for genes that maintain paternal-allelic 
silencing as well as those that differentially lose paternal-allelic silencing in stem cells 
upon Nup107, Nup62 and Nup153 depletion. A previous study also reported an interaction 
between HDAC4 and NPC proteins at boundary locations between active and repressed 
regions (Kehat et al., 2011). Chromatin immunoprecipitation of various HDAC proteins 
such as HDAC9 (identified in our shRNA screen) and HDAC4 at regions between or 
coinciding with NUP107, NUP62 and NUP153 and LADs might therefore be informative. 
 
145 
 
In my thesis, the Kcnq1ot1 domain was used as a model domain. Currently, there are two 
models of imprinted domain regulation, the ICR-mediated enhancer-blocking model and 
the ncRNA-mediated model. The H19 and the Gtl2 domains are examples of the former, 
while the Airn and Snrpn domain are examples of the latter. Future studies are required to 
investigate the role of NUP107, NUP62 and NUP153 in regulating other imprinted 
domains in XEN, ES and TS cells. Investigation of the H19, Gtl2, Airn and Snrpn domain 
will determine whether NUP107, NUP62 and NUP153 play a role in the regulation of these 
domains, and whether they are regulated in manner similar to the Kcnq1ot1 domain. 
 
Once the mechanisms are clearly determined in ES, TS and XEN cells, future studies will 
be required to investigate the role of nucleoporins during development. To determine 
whether nucleoporins are involved in Kcnq1ot1 imprinted domain regulation during 
preimplantation development, genetic mutations could be generated using CRISPR 
technology. To determine whether nucleoporin mutations lead to aberrant Kcnq1ot1 
ncRNA and paternal allelic reactivation, imprinted expression analyses can be conducted 
for the Kcnq1ot1 ncRNA and protein-coding genes in blastocyst stage embryos. Imprinted 
methylation analysis can also be performed to assess whether DNA is maintained as it was 
in stem cells. DNA/RNA FISH using Kcnq1ot1 probes can be performed to visualize the 
effects of nucleoporin mutations in individual cells of the blastocyst embryo, allowing us 
to examine cells with different fates, i.e. epiblast precursors, primitive endoderm and 
trophectoderm. These investigations will delineate the mechanism of nucleoporin-mediate 
regulation of the Kcnq1ot1 domain during preimplantation development. Further 
investigation of postimplantation stages of development will also be important. 
Midgestation embryos carrying a paternally-inherited Kcnq1ot1 ICR deletion or Kcnq1ot1 
ncRNA truncation exhibit domain-wide loss of paternal allelic silencing. To determine 
whether nucleoporins act domain-wide in control and mutant postimplantation 
conceptuses, embryonic, placental and yolk sac tissues can be examined using the same 
assays that I used for XEN, ES and TS cells. These experiments will address the 
developmental regulation of the Kcnq1ot1 imprinted domain by nucleoporins.  
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Overall, the novel mechanistic action of nucleoporin proteins at the Kcnq1ot1 imprinted 
domains opens a new dimension to understand imprinted domain regulation and the role 
of nucleoporins as epigenetic regulators. 
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Windsor, February 4-5, 2011 
19. Sachani SS and Crawford MJ. ‘What masters eye development, Pax6 or Six3?’ 13th 
International Xenopus Conference, Lake Louise, Alberta, Canada. September 12 – 16, 
2010 (Poster Presentation) 
20. Sachani SS and Crawford MJ Role of Six3 in Xenopus eye and brain development 
(Oral Presentation) – Ontario Biology Day Conference, University of Windsor, 
March 23-24, 2009 
 
PROFESSIONAL MEMBERSHIPS 
2009 – Present, Member Society of Developmental Biologists 
2009 – Present, Canadian Society of Biochemistry, Molecular and Cellular Biology 
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WORK EXPERIENCE 
Globalink Graduate Advisor      2012 – 2015 
Mitacs Globalink Foundation, Canada 
• Advisor and support for students attending Western University in the STEM 
(Science, Technology, Engineering and Mathematics) fields during Summer from 
around the world. 
Graduate Teaching Assistant      2009 – 2011 
University of Windsor, Windsor, ON. Canada. 
• Introductory Microbiology and Techniques, Laboratory Instructor (Fall 2009) 
• Medical Microbiology and Techniques, Laboratory Instructor (Winter 2010) 
• Embryology & Developmental Biology – Teaching Assistant (Fall 2010) 
• Guest Lecturer, Embryology & Developmental Biology, (Fall 2010, 4 lectures) 
• DNA Biotechnology Molecular Techniques, Laboratory Instructor (Winter 2011) 
 
Assistant Instructor/Course Coordinator     2008 - 2011 
Canterbury College, University of Windsor, Windsor, ON. Canada 
• International Engineering/Medical Graduate Program (June 2010 – April 2011) 
• International Medical Graduate Program (January 2008 – April 2010)  
SUPERVISORY EXPERIENCE 
University of Western Ontario 
2014 Summer -  Taylor Smith, Biotechnology Internship candidate 
2013 – 2014 – Alisha Bester, 4th Year undergraduate project student) 
2013 Summer – Josef Ianni, Volunteer summer student  
University of Windsor 
2011 Summer – Touba Warsi (NSERC Summer Student) 
2010-2011 – Candace Rapchak (NSERC Summer/4th year undergraduate project student)  
2010 – 2011 – Todd Baert (4th Year undergraduate project student) 
2010 – 2011 – Ahsan Farooqi (Volunteer) 
UNIVERSITY INVOLVEMENT 
University of Windsor  
2010 – 2011, University Senate, Student Standing Committee  
2010 – 2011, International Student Retention Working Committee 
2010 – 2011, President of International Student Society 
2009 – 2010, Vice President of Accessibility, International Student Society  
2009 – 2010, I.T. Steering Committee, Canterbury College 
2008 – 2010, Education Program Development Committee, Canterbury College  
2010 – 2011, International Student Health Insurance Working Committee  
2010 – 2011, Student Diversity Action Committee, Human Rights  
2009 – 2011, International Student Scholarship Committee, ISS.   
2008 – 2009, Awards and Scholarship Selection Committee, Canterbury College  	
